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Development of an in-vitro animal model to evaluate novel pharmaceutical
approaches to DED management
by Francesco MENDUNI
In the ophthalmic field, multifactorial pathologies such as Dry Eye Disease (DED) and
cataract are largely studied in living animal models that can fail to precisely mirror the
complexity of these conditions in humans. Recent advances in biomedical technolo-
gies have improved the reliability of in-vitro/ex-vivo animal alternatives, and to date,
the corneal and crystalline lens tissue have been independently maintained physio-
logically stable for 10 days.
This thesis details the development of a novel and complete ex-vivo anterior eyemodel,
which is capable of sustaining both the cornea and crystalline lens in a physiologically
stable state in loco for 7 days. The platform is based on porcine eyes, which represent
a high quality and reliable human tissue source substitute, and being slaughterhouse
waste, also perfectly align the project with the 3Rs principle of replacing, refining and
reducing living animal experimentation. The model is modular and scalable, allow-
ing for the maximisation of experimental reliability, and the minimisation of waste
and energy use. In addition, the whole system is designed to be fitted in a laminar
flow cabinet, avoiding external biological contamination, and is easily transportable
between tissue engineering laboratories, maximising accessibility.
The model was validated estimating cell viability over time. Stromal fibroblasts were
found to be viable up to the seventh day of culture, and corneal and crystalline lens
tissue maintained their transparency over the culturing period. Dry Eye Disease was
successfully induced in the model by irrigating the ocular surface every 40s, and vali-
dated using impression cytology technique. Moreover, due to the unique presence in
loco of the crystalline lens, the model was also used as a platform to perfect cataract
surgery and successfully implant intraocular lenses (IOLs).
The novel and complete ex-vivo anterior eye model developed in this thesis provides
further insights into pre-clinical anterior segment investigations in ophthalmology,
taking a step forward toward bridging the existing gap between in-vitro and in-vivo
biomedical technologies.
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Desarrollo de un modelo animal in-vitro para evaluar nuevos fármacos para el
tratamiento de ojo seco.
Doctorando Francesco MENDUNI
Dentro del campo oftalmológico, patologías multifactoriales como Enfermedad del
Ojo Seco (EOS) y Cataratas son ampliamente estudiadas a través de modelos animales
que no reproducen con exactitud estas condiciones en humanos debido a su comple-
jidad. Los recientes avances en la tecnología biomédica han mejorado la fiabilidad
de modelos animales in-vitro/ex-vivo, y hasta el momento, el tejido de la córnea y
cristalino se hanmantenido fisiológicamente estables de forma independiente durante
10 días.
Esta tesis describe el desarrollo de un nuevo y completo modelo de ojo anterior ex
vivo, que es capaz de mantener tanto la córnea como el cristalino en un estado fisi-
ológico estable durante 7 días. La plataforma se basa en ojos porcinos, que represen-
tan una fuente alternativa al tejido humano de alta calidad y fiable, y al tratarse de
residuos de matadero, también alinea perfectamente el proyecto con el principio 3Rs
de reemplazar, refinar y reducir la experimentación con animales vivos. El modelo
es modular y escalable, permitiendo la maximización de la fiabilidad experimental y
la minimización de los residuos y el uso de energía. Además, todo el sistema está
diseñado para instalarse en un gabinete de flujo laminar, evitando la contaminación
biológica externa, y facilitando su transporte entre los laboratorios de ingeniería de
tejidos, aumentando así la accesibilidad del mismo.
El modelo fue validado estimando la viabilidad celular en el transcurso del tiempo.
Se encontró que los fibroblastos estromales eran viables hasta el séptimo día de cul-
tivo, y el tejido corneal y cristalino mantuvieron su transparencia durante el período
de cultivo. La enfermedad del ojo seco se indujo con éxito en el modelo mediante ir-
rigación de la superficie ocular cada 40 s, y se validó utilizando la técnica de citología
de impresión. Además, debido a que la posición del cristalino no se ha alterado, el
modelo también se utilizó como plataforma para perfeccionar la cirugía de cataratas e
implantar con éxito lentes intraoculares (LIOs).
El novedoso y completo modelo de ojo anterior ex-vivo desarrollado en esta tesis pro-
porciona información adicional sobre investigaciones pre-clínicas del segmento ante-
rior en oftalmología, dando un paso adelante para reducir las diferencias existentes
entre las tecnologías biomédicas in-vitro e in-vivo.
Palabras clave: Ex-vivo; Ex-vitro; Cultivo Órganos; Cornea; Lente cristalina; Ojo Seco.
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If you find a need, fulfil the gap.
Lailah Gifty Akita
1
Introduction
Pathological ocular conditions such as Dry Eye Disease (DED) and cataract hold im-
portant and disruptive ramifications in terms of patient function, satisfaction, and
quality of life (Craig et al. 2017, Rao et al. 2011). Governments are constantly striving
for new and better treatments to combat eye disease and sight loss, however, less than
2% of all UK medical research funding is directed at ocular disease (Pezzullo et al.
2018). Consequently, there is a real need for increasing value for money in medical
research and intervention/ management strategies. As such, multidisciplinary ap-
proaches which engage multiple centres in different countries, where scientists work
together innovatively at the frontier of research in engineering, biology, chemistry and
medicine to design novel products and procedures are of significant value in solving
todays medical challenges.
DED affects at least 344 million people worldwide (Figure 1.1), and is one of the most
frequent causes of patient visits to eye care practitioners (Craig et al. 2017). However,
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fully understanding the epidemiology and best management of DED continues to be
a challenge. Due to the significant corneal consequences of DED, human eye research
is often impractical or limited, and as such, animal eye models have been extensively
used to simulate the condition in research studies (Chan et al. 2014).
FIGURE 1.1: Dry Eye Disease (DED): a growing reality degrading qual-
ity of life and vision.
To date, in-vivo animal models have been used widely in multidisciplinary biological
and medical research as a means of investigating physiological mechanisms and for
the evaluation and refinement of novel therapies prior to first-in-human clinical trials
(Barre-Sinoussi & Montagutelli 2015). In the field of ophthalmology, a large propor-
tion of such models have been used to evaluate the effect on the ocular tissues from
administered molecules in terms of factors such as irritation and toxicity. However, as
far as the ocular surface is concerned, these models remain limited as they do not re-
produce the complexity and chronicity of frequent and debilitating conditions such as
DED or Meibomian Gland Dysfunction (MGD) (Barre-Sinoussi & Montagutelli 2015,
Barabino & Dana 2004).
50 years ago, the 3Rs principle (Table 1.1) was developed as an attempt to provide a
framework for conducting humane animal research (Kirk 2018), and since then, the
scientific community has largely moved away from in-vivo towards in-vitro studies.
Technological advances over this period have produced repeatable and reliable in-
vitro platforms which have made it now possible to investigate the extrinsic parame-
ters of ocular surface diseases such as tear film deficiency or environmental stress in a
fraction of the time, at a much reduced cost, and with greater predictive relevance for
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humans (Choy, Cho, Benzie, Choy & To 2004).
TABLE 1.1: Definitions of the 3Rs: Replacement, Reduction and Refine-
ment.
Principle Description
Replacement
Use of technologies or approaches directly replacing
or avoiding the use of animals in experiments where
they would otherwise have been used.
Reduction
Application of methods minimising the number of
animals used per experiment or study consistent with
the scientific aims.
Replacement
Use of technologies or approaches directly replacing
or avoiding the use of animals in experiments where
they would otherwise have been used.
In-vitro cell lines have proved particularly valuable for pharmacological screening,
and for characterising and examining the physiological behaviour of individual cell
types. However, they do have clear limitations in terms of replicating the complex
interactions that occur between the different structures of a living organ, especially in
the eye (Shafaie et al. 2016). For this reason, ex-vivo models may be a more promis-
ing prospect for replicating a natural eye environment, and also have the potential
for replacing or minimising the use of laboratory animals (Stanworth & Naylor 1950,
Guindolet et al. 2017).
Though recent work has provided a means to maintain the cornea (Guindolet et al.
2017) or crystalline lens (Cleary et al. 2010) in a physiologically stable state for up
to seven days, an ex-vivo complete anterior eye model that is capable of preserving
both of these structures in loco for a similar time frame is elusive. As such, this thesis
has been written to describe a multidisciplinary collection of studies which centre on
using up-to-date biomedical engineering technology to develop and test a complete
ex-vivo anterior eye model. The ultimate aim of this work was to generate a robust
scientific platform which would have multiple future applications and be ultimately
translatable to human donor eyes and, therefore, could play a pivotal role in bridging
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the existing gap between in-vitro and in-vivo anterior segment investigations in oph-
thalmology.
This thesis begins with a systematic and detailed literature review (Chapter 2). This
was initially conducted to deduce the most appropriate parameters to ensure that
physiological eye conditions were replicated as closely and accurately as possible.
From this knowledge, an optimal preservation technique was developed to maximise
corneal transparency and minimise biological tissue deterioration in a porcine eye
model (Chapter 3). The anatomical biometry of the porcine eyeball was also exten-
sively characterised to generate reproducible baseline data (Chapter 4). Chapter 5 de-
scribes how this knowledge was applied to develop a new ex-vivo anterior eye model
for assessing tear stability and ocular surface damage. Furthermore, the evaluation of
the instrument at tissue and cellular level will also be detailed. The final experimental
chapter (Chapter 6) will address how the instrument was re-engineered to provide a
novel and reliable training platform for cataract surgery. The final chapter (Chapter 7)
will provide a summary of the research project, will review the answers to the research
questions posed, will comment on study limitations and will make recommendations
for future investigations.
16
2
The Historical Evolution of Ex-Vivo Ocular
Surface Models: a Systematic Review
2.1 Introduction
The human eye is a masterpiece of engineering characterised of highly specialised
structures functionally linked to allow vision. Among all these structures, the tear
film and ocular surface play a key role in the maintenance of adequate vision as they
refract light through the lens and onto the retina for photoreceptor activation, while
protecting the eye from injury and external pathogens (Gipson 2007).
Ocular pathologies like Dry Eye Disease (DED), which selectively affect these parts
of the eye of millions of people throughout the world, are currently largely stud-
ied observing overt clinical signs in animal models that fail to precisely mirror the
complexity of these conditions (Craig et al., 2017). As a consequence, many human
17
Chapter 2. The Historical Evolution of Ex-Vivo Ocular Surface Models: a Systematic Review
clinical trials do not result in acceptable safe and efficacious advances, making the
progress slow and incremental (Barabino & Dana 2004). However, recent advances
in biomedical technologies have improved the reliability of alternative techniques for
ocular investigation, providing economic and logistical advantages for animal alter-
natives. These techniques include ex-vivo models of deceased animal tissue and in-
vitro cell culture models (Shafaie et al. 2016). Although the use of cell culture models
is particularly valuable in the early stages of investigation (e.g. screening potential
pharmacologic agents or novel biomaterials), it has clear limitations in replicating the
complex anatomy and physiology of the ocular surface. Therefore, investigators have
developed ex-vivo model that could store the ocular surface in its physiological state,
maintaining structure integrity (Guindolet et al. 2017).
This chapter systematically reviews ex-vivomodels of the ocular surface from the earli-
est reported to 2018, discussing the key features required to best replicate the anterior
eye.
2.2 Methods
This systematic review was conducted in accordance with the procedures developed
by the Cochrane Collaboration (Higgins & Green 2011) and the Preferred Reporting
Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines (Moher et al.
2009).
2.2.1 Data
Three electronic databases were searched from the earliest date: Web of ScienceTM
Core Collection, MEDLINE and Scopus. English language restriction was applied.
The following search strategy was designed for Web of ScienceTM Core Collection
and it was modified to search MEDLINE and Scopus:
1. artificial-anterior-chamber;
2. isolated-corne*;
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3. trabecular-meshwork NEAR/3 culture*;
4. (in-vitro OR ex-vitro OR ex-vivo) NEAR/3 (eye NEAR/3 model);
5. culture* NEAR/3 (anterior-chamber OR anterior-segment);
6. perfus* NEAR/3 (anterior-chamber OR anterior-segment) OR (perfus* NEAR/1
corne*).
Additionally, a hand search of reference lists of the retrieved papers was completed.
The electronic sources were last searched on 1st August 2018.
2.2.2 Study Selection
Included in this review were ex-vivo models that used enucleated eyeballs, or com-
ponents thereof, for the short or long-term maintenance of normal physiological and
biochemical functions of the ocular surface. Therefore, excluded from this reviewwere
studies based of the following models:
• Cell line models;
• Static organ culture;
• In vivo models;
• Phantom models (e.g. Finite Element Methods models, acrylic glass models);
• Models of organs different from the eye (e.g. kidney, vessels, mammary cancer);
Titles and abstracts resulting from the literature searches were reviewed, according
to the eligibility criteria stated above. Full-text copies of all relevant articles were
obtained for further assessment and inclusion in the review.
2.3 Results
A total of 4066 titles and abstracts were identified from the electronic searches as of Au-
gust 2018, Figure 2.1. After removing the duplicates, titles and abstracts were screened
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FIGURE 2.1: Flow of study selection. 4079 titles and abstracts were
identified through database and online searching. After removing the
duplicates and screening titles and abstract 483 studies were reviewed.
Finally, 275 studies were included in the review after full-text examina-
tion.
and 483 studies were identified as potentially relevant for this review. Finally, a full-
text review identified 275 eligible articles.
The original concept of eye modelling dates as far back as the 4th c. BC, when Aristo-
tle highlighted the chick as the greatest model to use for studying eye development in
his Book II of Generation of Animals. However, it is only in the 1950s that Stanworth
and Naylor devised the first artificial chamber in which the birefringence of the iso-
lated cornea could be studied under near-physiological conditions in polarised light
(Stanworth & Naylor 1950).
In particular, the isolated cornea was clamped between two chambers filled with
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Ringer’s solution (Figure 2.2), and polarised light from a slit lamp source was colli-
mated onto the corneal specimen. As the purpose of the study was the pure evalua-
tion of corneas physical properties, this apparatus far from satisfied the requirement
of maintaining the isolated tissue in a physiological condition.
FIGURE 2.2: Schematic diagram of the pressure apparatus introduced
by Stanworth and Naylor (1950). It consisted of two chambers between
which the isolated cornea was clamped. Strain-free glass plates close
the apparatus at the front and the back, so that both chambers could be
filled with any required fluid at any desired pressure. Figure redrawn
by the authors.
2.3.1 Corneal permeation chamber(s)
A crucial step forward was made around 10 years later by Donn and their research
group (Donn et al. 1959). Basing their chamber model on the one developed by Uss-
ing and Zerahn for the frog skin (Ussing & Zerahn 1951), the authors were able to
maintain the isolated rabbit cornea viable for up to 8 hours, while studying its per-
meability. Corneal viability was assessed by performing potential, resistance and con-
ductance measurement across the excised tissue, Figure 2.3.
This work pioneered the use of horizontal diffusion cells for studying drug perme-
ation and ionic diffusion across corneas, which is the reason why these models have
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FIGURE 2.3: Schematic diagram of the diffusion chamber introduced by
Donn et al. (1959). It consisted of two Lucite chambers between which
the isolated cornea was clamped. Motor-driven syringes were used to
perfuse artificial aqueous humour into the chambers. The potential dif-
ference across the cornea wasmeasured connecting the outflow beakers
by means of Calomel electrodes to a voltmeter. Corneal resistance was
calculated passing a known current through the cornea via the inflow
tubes and evaluating changes in potential. Figure redrawn by the au-
thors.
been labelled as corneal permeation chamber(s) in this review. Several researchers
modified the design of these chambers over the years to try to replicate in vivo con-
ditions more closely. For example, in 1990 Richman et al. introduced an additional
infusion pump for controlling tear film turnover and varying the contact time of the
cornea with the drug (Richman & Tang-Liu 1990), and Madhu et al. combined the
chamber with quantitative high performance liquid chromatography to assess both
corneal and scleral permeability in human ocular tissues (Madhu et al. 1998).
The main parameters of these studies are summarised in Table 2.1, which identifies
that the time frame of these models was limited to 11 hours. This is mainly due to the
fact that the corneal hydration was not satisfactorily maintained normal during the
period under study. In fact, some studies reported grossly opaque corneas by the end
of the experiments, but still relatively stable electrical parameters over the experimen-
tal period (Ploth & Hogben 1967).
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TABLE 2.1: Key parameters of main permeation studies from 1959 to
2008. / = not reported.
Source IOP [mmHg] MM T [◦C] FR [µ l/min] Tissue TF [hr]
(Donn et al. 1959) 18 BR 35 / Rabbit 8
(Green 1965) / BR 35 / Rabbit 2
(Klyce 1972) 15 BR 34 / Rabbit/Frog 2
(Klyce et al. 1973) / BR 34 / Rabbit 6
(Fischer et al. 1974) / / / / Rabbit /
(Graves et al. 1976) 15 / 35 / Frog 1
(Klyce 1977) 10-30 BR 35 / Rabbit 11
(Mark & Maurice 1977) 11 BR 35 5000 Rat 7
(Spinowitz & Zadunaisky 1979) / BR 35 / Frog /
(Candia & Podos 1981) / BR 23-24 / Frog 7
(Rojanasakul & Robinson 1990) / / 35 / / /
(Richman & Tang-Liu 1990) / BR 35 / Rabbit 2
(Kwok & Klyce 1992) / BR 37 / Rabbit 2
(Madhu et al. 1998) / BR 35 / Human 4
(Valls et al. 2008) 13-19 BR 35 / Rabbit 2.5
To overcome this limitation, researchers around the world started to devise models
for the maintenance of normal corneal hydration. In these models, functional and
ultrastructural changes in isolated cornea during perfusion were studied by means
of specular microscopy, an imaging technique that added a new dimension to corneal
storage studies as it enabled researchers to dynamically profile corneal thickness while
observing the endothelial morphology (Maurice 1968). An example of this apparatus
is shown in Figure 2.4.
FIGURE 2.4: Schematic diagram of the perfusion chamber introduced
byMcCarey et al. (1973). The isolated cornea was mounted in a vertical
chamber enclosed in a brass water-jacket and mounted under a specu-
lar microscope. Endothelial perfusion was performed at 30 µl/min un-
der a pressure of 15 mmHg. The corneal epithelium was covered with
medical grade silicone oil for microscopic examination. Figure redrawn
by the authors.
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The first successful model of this type was devised by Mishima and Kudo in 1967.
They excised rabbit corneas, mounted them in small Plexiglas perfusion chambers,
and followed changes in their thickness while incubated. With this system, the au-
thors were able to carry out a perfusion of both the posterior and the anterior surfaces
of the cornea, and to extend the time frame to over 10 hours (Mishima&Kudo 1967). A
step further was made in 1972 by Dikstein and Maurice, who developed an improved
method of mounting the cornea and determining its thickness (Figure 2.5) (Dikstein
& Maurice 1972). In particular, their techniques and perfusion medium were simpler
than those of Mishima and Kudo and, although they only achieved a preparation lifes-
pan of 5-6 hr, this seemed to allow a fuller reversal of the cornea swelling in the period
of study.
FIGURE 2.5: Schematic diagram of the corneas mounting method intro-
duced by Dikstein and Maurice (1972). The cornea was pressed on to
a cannulated methacrylate rod and was held in place by a light suction
during the dissection. The perfusion chamber was then pressed down
to form a seal, and the perfusion fluid was circulated through the inside
of the chamber under a positive pressure of 20 mmHg. Figure redrawn
by the authors.
This model was extensively used by other authors not only for showing the existence
of a correlation between corneal swelling rate, endothelial pattern, and cellular in-
tegrity (McCarey et al. 1973), but also to evaluate the effect of different irrigating so-
lution on the cornea (Yagoubi et al. 1994), or to explore contact lens adhesion (Rae &
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TABLE 2.2: Key parameters of main studies based on the model devel-
oped by Dikstein and Maurice in 1972. / = not reported.
Source IOP [mmHg] MM T [◦C] FR [µ l/min] Tissue TF [hr]
(Mishima & Kudo 1967) 15-20 Kei No.4 34 36-46 Rabbit 10
(Dikstein & Maurice 1972) 11 BSS 36 10 Rabbit 6
(McCarey et al. 1973) 15 BR 34 30 Rabbit 6.5
(McCarey et al. 1976) 15 SC 34 60 Rabbit 5
(Nyberg et al. 1977) / / / / Rabbit 3
(O’Brien & Edelhauser 1977) 15 BR 34 / Rabbit /
(Van Horn et al. 1977) 15 BR 37 / Rabbit/Human 5
(Whikehart & Edelhauser 1978) 15 LR/BR 37 / Rabbit 5
(Stern et al. 1981) 15 GBR 37 20.6 Rabbit 3
(Hull et al. 1982) 15 BR 37 / Rabbit 3
(Hull et al. 1985) 15 BR 37 16.6 Rabbit 3
(Watsky et al. 1990) / GBR / / Rabbit 2
(Wilson & Chalmers 1990) 20 GBR 35 100 Rabbit 2.5
(Rae & Huff 1991) 11-18.5 M199 / 17-25 Rabbit 3
(Doughty 1992) 11 BSS 35 25 Rabbit 2.5
(Srinivas & Maurice 1992) 11 BSS / 60 Rabbit 6
(Yagoubi et al. 1994) 11 TC199 35 41 Rabbit 7.5
(Riley et al. 1998) / BR / 100 Rabbit 1
(Thiel et al. 2001) 18 BSS Plus 35 17 Porcine 14
(Holley et al. 2002) 15-20 BSS Plus 37 0.07 Rabbit/Human 4
(Thiel et al. 2002) 18 BSS Plus 35 17 Porcine/Human 14
(Brereton et al. 2005) 18 BSS Plus 35 17 Porcine 10
(Dawson et al. 2007) 15-55 BSS Plus 37.5 0.07 Human 5
(Doughty & Bergmanson 2008) 29.5 BSS/HEPES 37 66 Sheep 10
Huff 1991). The main parameters of several studies based on this model are reported
in Table 2.2 . Independently from what has been analysed with these models, all these
studies involved the use of human or animal material and clamping of the corneoscle-
ral button into a special holder where the posterior chamber could be perfused with
medium and an appropriate pressure gradient could be applied. For this reason, these
systemswere successful for evaluating the corneal endothelium, though no evaluation
was made of the corneal epithelium or stroma.
2.3.2 Corneal perfusion model(s)
The concept of perfusing isolated tissue has also been extensively used to study glau-
coma. Elevated Intraocular Pressure (IOP) constitutes the primary risk for the de-
velopment of the most common form of glaucoma, primary open-angle glaucoma
(Sommer et al. 1991). IOP is determined by a dynamic equilibrium between aque-
ous humour production and outflow and high IOP can theoretically be caused by
either an excessive production of aqueous humour or reduction of its outflow or a
combination of both (Johnstone & Grant 1973). With regards to this, the trabecular
meshwork (TM)/Schlemms canal outflow pathway system constitutes the main route
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by which the aqueous humour exits the anterior chamber of the eye (Bill & Phillips
1971). During the years, several models have been developed and evolved to closely
replicate the in vivo state of the aqueous humour outflow, from both a histologic and
molecular perspective. These models utilise either the whole eyeball or isolated cor-
neoscleral preparations, and they have been included in this review since they might
be optimised to achieve the final objective of producing a complete ex-vivo anterior
eye model.
Perfusion models based on whole eyeball
Whole eyeball models are based on the aqueous perfusion of enucleated whole eyes as
a convenient and direct means for quantitative evaluation of facility of aqueous out-
flow.
The first successful quantitative aqueous perfusion on enucleated whole eyes long af-
ter death was performed by Grant in 1963. He developed a specific fitting by which
he was able to perform evaluation on the whole eyeball for a period of 5 hours. Dur-
ing its procedure, globes were placed in a silicone rubber mould which enveloped the
posterior segment to the equator. The anterior half was covered with absorbent paper
saturated with perfusion solution. A 5 mm corneal trephining was performed in all
eyes to permit insertion of a stainless steel corneal perfusion fitting (Grant 1963).
Following Grants studies, researchers all over the world emulated these experiments
to evaluate aqueous outflow functions not only in the human eye, but also in bovine,
monkey and porcine eyes. Details of these studies are summarised in Table 1.3.
Among these studies, Choy et al. demonstrated an ex-vivo model of DED for the first
time in 2004, using freshly enucleated porcine eyes (Choy, Cho, Benzie, Choy & To
2004). With this model, researchers were able to simulate DED conditions of different
severity changing blinking intervals and/or volume of "lacrimation". For achieving
so, they fixed the entire eyeball in a plastic holder, with the nictitating membrane
placed just above the cornea, and by using a movable mechanical arm, they could
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TABLE 2.3: Key parameters of main perfusion models based on the
whole eyeball. / = not reported, Vrb: Variable.
Source IOP [mmHg] MM T [◦C] FR [µ l/min] Tissue TF [hr]
(Grant 1963) / / 34 / / 5
(Kupfer & Ross 1971) 11.5-16 Saline / / Human /
(Johnstone & Grant 1973) -2-50 PBS / / Human 2.5
(Epstein et al. 1978) 25 DPBS 22 / Human 4
(Epstein et al. 1982) 25 DPBS 22 / Monkey/Bovine 4
(Moses et al. 1982) 25-40 Saline / / Human /
(Nguyen et al. 1988) 15 H2O2 / 1000 Bovine 3
(Johnson et al. 1993) 15 DPBS 34 / Bovine 5
(Epstein et al. 1997) / DPBS 25 / Bovine/Porcine 5
(Epstein et al. 1999) 15 DPBS 25 / Porcine 5
(Overby et al. 2002) 15 DPBS 34 / Bovine 5
(McDonnell et al. 2003) Vrb BSS / / Human/Rabbit /
(Choy, Cho, Benzie, Choy & To 2004) / DPBS 21-23 / Porcine 4
(Choy, Shun, Cho, Benzie & Choy 2004) / DPBS / / Porcine 4
(Fyffe et al. 2005) / DMEM 20 / Porcine /
(Kompella et al. 2006) / PBS 37 / Bovine 1
(Lu et al. 2008) 15 DPBS 34 / Bovine 3
(Choy et al. 2008) / DPBS 21-23 / Porcine 4
(Johnson et al. 2010) 10 DPBS 34 / Porcine 1
(Spoler et al. 2010) 10 BR 32 / Rabbit 6
(Kray et al. 2011) 10 BR Plus 32 / Rabbit 6
(Zhu et al. 2013) 7-30 DPBS 34 / Bovine /
(Chan et al. 2014) 7-30 DPBS 22-24 / Porcine /
(Hunter et al. 2014) Vrb DMEM 22-24 2.5 Human /
(Johannesson et al. 2014) 20-40 Saline / / Porcine /
(Wang et al. 2014) / Barany’s Medium 40 / Porcine /
sweep the membrane over the cornea surface simulating blinking (Figure 2.6).
Six years later, Spoler et al. used a short-term approach of the Ex Vivo Eye Irritation
Test to mimic DED and monitored corneal desiccation by two dimensional quantita-
tive Optical Coherence Tomography (OCT) analysis (Figure 2.7) (Spoler et al. 2010).
Moreover, by using three dimensional OCT analysis, they were also able to analyse
deep structural disorders in the cornea, visualising damages within the epithelium
and the anterior stroma (Kray et al. 2011).
What is interesting in all these models is that the time frame in which the tissue re-
mains physiologically stable is limited to 5 hours. This is linked to the increasing
mortality rate of endothelial cells due to the non-efficient corneal perfusion. For this
reason, these ex-vivo studies have mainly been used to analyse topical drug applica-
tion as high solute uptake is desired in a short time with eye drops. However, this
limited experimental time frame of only several hours makes these models not suc-
cessful tools for studying pathologies such as DED, for which a detailed analysis of
corneal regeneration following corneal drying under different treatment conditions is
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FIGURE 2.6: Diagram of the pDEM set up introduced by Choy et
al. (2004).The whole porcine eyeball with conjunctiva tissue, lacrimal
gland and the nictitating membrane was fixed in a movable arm. The
nictitating membrane was swept over the corneal surface upon move-
ment of the movable in order to replicate blinking. Figure redrawn by
the authors.
essential. To expand the usable time scale for experiments, researchers developed al-
ternative ex-vivo eye models based on isolated corneoscleral preparations, particularly
focusing on the TM.
Perfusion models based on isolated corneoscleral buttons
Johnson and Tschumper introduced the most successful ex-vivo model of the TM in
1987. They were able to maintain human cells of the outflow pathway functional at
the molecular level for a period of 21 days (Johnson & Tschumper 1987). In partic-
ular, after bisecting the globe at the equator, they removed vitreous and lens under
sterile conditions. After clamping the anterior segment in a modified Petri dish, they
perfused the eye with Dulbeccos Modified Eagle Medium (DMEM) with a mixture of
antibiotics at a normal human flow rate of 2.5 µl/min (Figure 2.8). Explants were cul-
tured at 37◦C in an atmosphere of 5% CO2 and variations in IOP were continuously
monitored without altering the culture by connecting a pressure transducer to a sec-
ond access cannula built into the dish.
28
Chapter 2. The Historical Evolution of Ex-Vivo Ocular Surface Models: a Systematic Review
FIGURE 2.7: Experimental setup of short-term Ex Vivo Eye Irrita-
tion Test, Spoler et al. (2010). Rabbit eyeballs were placed into a
temperature-controlled water bath. Lacrimation was simulated by us-
ing a perfusion pump for applying single drops of Ringers solution at
a defined interval onto the corneal surface. A gas hose with internal
diameter of 3.0 mm was used to flush dried air at variable flow rate
over the cornea, simulating different environmental conditions. Figure
redrawn by the authors.
By using this method, researchers were not only able to prove that trabecular cells
require a minimum perfusion rate of approximately 1 µl/min for long-term survival
(Johnson 1996), but were also able to study gene transfer in human donor tissue, facil-
itating the evaluation of a correlation of the effects of specific altered protein concen-
trations with changes in outflow function (Borras et al. 1998). Moreover, this model
was used to investigate Human Corneal Epithelial Cells (HCEC) transplantation (Pa-
tel et al. 2009), and to determine the influence of TM bypass stent on human outflow
facility (Bahler et al. 2012). The main characteristics of several studies that used this
method to characterise the regulation of outflow facility in isolated perfused human
eyes are presented in (Table 2.4).
These models were based on human donor eyes, which are limited by their avail-
ability and high cost. More important, healthy human donor eyes are prioritised for
corneal transplantation, therefore, those available for research are generally not of the
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TABLE 2.4: Key parameters of main perfusionmodels based on isolated
human corneoscleral buttons. / = not reported, Vrb: Variable.
Source IOP [mmHg] MM T [◦C] FR [µ l/min] TF [d]
(Johnson & Tschumper 1987) vrb DMEM 37 2.5 28
(Johnson & Tschumper 1989) vrb DMEM 37 2.5 28
(Buller et al. 1990) vrb DMEM 37 2.5 7
(Johnson et al. 1990) vrb DMEM 37 2.5 21
(Tschumper et al. 1990) vrb / / 2.5 21
(Clark et al. 1995) vrb DMEM / 2 21
(Johnson 1996) vrb DMEM 37 0.5-10 21
(Johnson 1997) vrb DMEM 37 2.5 14
(Borras et al. 1998) vrb DMEM 37 2.5 7
(Borras et al. 1999) vrb DMEM 37 3-4.5 5
(Fautsch et al. 2000) vrb DMEM 37 2.5 10
(Clark et al. 2001) vrb MEM 37 2.5 10
(Pang et al. 2001) vrb DMEM 37 2.5 18 hr
(Borras et al. 2002) vrb DMEM 37 3 7
(Loewen et al. 2002) vrb DMEM 37 2.5 5
(Vittitow et al. 2002) vrb DMEM 37 3-4 7
(Vittitow & Borras 2002) vrb DMEM 37 3-4 3
(Perruccio et al. 2003) vrb DMEM 37 2.5 8
(Santas et al. 2003) vrb DMEM 37 2.5 3
(Fautsch et al. 2003) vrb DMEM 37 2.5 21
(Bahler, Fautsch, Hann & Johnson 2004) vrb DMEM 37 2.5 28
(Bahler, Hann, Fautsch & Johnson 2004) vrb DMEM 37 2.5 /
(Bahler, Smedley, Zhou & Johnson 2004) vrb DMEM 37 2.5 5
(Gonzalez et al. 2004) vrb DMEM 37 3 /
(Gottanka et al. 2004) vrb DMEM 37 3 15
(Liton, Liu, Challa, Epstein & Gonzalez 2005) vrb DMEM 37 3 4
(Liton, Luna, Challa, Gonzalez & Epstein 2005) vrb DMEM 37 3 /
(Rao et al. 2005) vrb DMEM 37 3 4
(Fautsch et al. 2006) vrb DMEM 37 2.5 4
(Fleenor et al. 2006) vrb DMEM 37 2.5 6
(Stamer et al. 2007) vrb DMEM 37 2.5 7
(Wan et al. 2007) vrb DMEM 37 2.5 8
(Wordinger et al. 2007) vrb DMEM 37 2.5 8
(Bahler et al. 2008) vrb DMEM 37 2.5 3
(Perruccio et al. 2008) vrb DMEM 37 2.5 8
(Ramos & Stamer 2008) vrb DMEM 37 2.5 6
(Stamer et al. 2008) vrb DMEM 37 2.5 8
(Patel et al. 2009) vrb MEM 37 2.5 7
(Spiga & Borras 2010) vrb DMEM 37 3-6 6
(Chowdhury et al. 2011) vrb DMEM 37 2.5 10
(Bahler et al. 2012) vrb DMEM 37 2.5 3
(Keller et al. 2013) 8 DMEM 37 vrb 7
(Oh et al. 2013) vrb DMEM 37 2.5 9
(Chowdhury et al. 2015) vrb DMEM 37 2.5 1
(Vranka et al. 2015) 8.8 DMEM / vrb /
(Abu-Hassan et al. 2015) 8.34 DMEM 37 vrb 10
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FIGURE 2.8: Schematic diagram of the perfusion system introduced
by Johnson and Tschumper (1987). It consisted of a modified culture
dish (made of acrylic plastic) with a tight-fitting O-ring to seal the dis-
sected eye, creating a "closed eye". Cell culture medium was infused
at 2.5 µl/min using a syringe pump, and pressure within the eye was
monitored by inserting a pressure transducer into the second cannula.
Figure redrawn by the authors.
best quality. For this reason, researchers have looked for animal alternatives, which
are inexpensive and readily available. In particular, Ericksonlamy et al. were able to
demonstrate in 1988 that trabecular meshwork cells maintain their morphological in-
tegrity at constant outflow resistance in the perfused anterior segment of the bovine
eye (Ericksonlamy et al. 1988). In fact, for anatomical reasons, only in the bovine eye
can the ciliary muscle be easily detached from the trabecular meshwork, allowing a
complete dissociation of effects of ciliary muscle and trabecular meshwork on outflow
regulation. On the other hand, Hu et al. characterised the monkey anterior segment
organ culture system (Hu et al. 2006).
However, among all these animal alternatives, porcine eyes are the one who shows
more features in commonwith human eye, as it will be elucidated in chapter 3 (McMe-
namin & Steptoe 1991, Menduni et al. 2018). In addition, Bachmann et al. established
the applicability of the porcine perfusion model, conducting a detailed morphologic
analysis of the porcine outflow system and new ultrastructural investigations of the
juxtacanalicular region (Bachmann et al. 2006).
The main characteristics of several perfusion studies in isolated animal corneoscleral
buttons are presented in Table 2.5.
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TABLE 2.5: Key parameters of main perfusionmodels based on isolated
animal corneoscleral buttons. / = not reported, Vrb: Variable.
Source IOP [mmHg] MM T [◦C] FR [µ l/min] Tissue TF [hr]
(Zhou et al. 1998) vrb DMEM 37 16.7 Bovine 3
(Goldwich et al. 2003) vrb DMEM 37 4.4 Porcine 2
(Liu et al. 2005) vrb MEM 37 2.5 Monkey 7
(Bachmann et al. 2006) vrb DMEM 37 4.5 Porcine 7
(Hu et al. 2006) vrb DMEM 37 2.5 Monkey 8
(Webb et al. 2006) vrb DMEM 37 2.5 Bovine 4
(Zhao et al. 2006) 18 MEM 35 2.5 Bovine 10
(Vaajanen et al. 2007) 15 / / vrb Porcine /
(Rao et al. 2008) vrb DMEM 37 3 Porcine 8
(Zhang et al. 2008) vrb DMEM 37 2.5 Porcine 4
(Njie et al. 2008) 7.35 DMEM 37 vrb Porcine 2
(Bhattacharya et al. 2009) vrb DMEM 37 2.5 - 4.5 Porcine/Monkey 10
(Scott et al. 2009) 15 DPBS 34 vrb Bovine 4 hr
(Syriani et al. 2009) 10 DMEM 37 vrb Bovine 4 hr
(Lee et al. 2010) vrb DMEM 37 2.5 Monkey 4 hr
(Birke et al. 2011) vrb DMEM 37 4.5 Porcine 4
(Mao et al. 2011) vrb DMEM 37 5 Bovine 10
(Fujimoto et al. 2012) vrb DMEM 37 3 Porcine 7
(Kumar et al. 2012) 7.35 DMEM 37 vrb Porcine 1
(Qiao et al. 2012) 7.35 DMEM 37 vrb Porcine 1
(Giovingo et al. 2013) 7.36 DMEM 37 vrb Porcine 3
(Pinheiro et al. 2015) vrb MEM/HEPES 32 6.44 Rabbit 4
(Slauson et al. 2015) vrb DMEM 37 2.5 Monkey 8
(Pervan et al. 2016) vrb DMEM 37 4.5 Porcine 2
Despite the widespread usage of the model introduced by Johnson and Tschumper,
few studies have been conducted to investigate or make refinements to the original
technique of the culture system itself (Johnson & Tschumper 1989, Johnson 1996). In
addition, Bahler et al. examined one puzzling aspect of the model, the initial base-
line variable IOP, concluding that the variations in baseline IOP may be caused by cell
fragments and debris from dying cells in anterior segment tissues, suggesting to use
the cultures only after an initial period of stabilization (Bahler, Fautsch, Hann & John-
son 2004). This reversible phenomenon is generally referred to as "washout", and it
lasts several hours, depending on the animal specimen used. Moreover, Fautsch et al.
studied protein expression profiles from TM and effluent collected from anterior seg-
ment cultured with this model (Fautsch et al. 2003). They found that protein profiles
from fresh and cultured TM were quite similar, although the addition of supplements
such as Fetal Bovine Serum (FBS) may be required for protein profiles to match those
of the in vivo state.
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Five years later, Ramos and Stamer (Ramos & Stamer 2008) proposed a modified ver-
sion of the anterior segment perfusion to isolate and study the resistance generated by
the conventional outflow pathway in response to different biomechanical conditions
(Figure 2.9). In particular, a positive piston displacement pump was used in combina-
tion with a syringe pump to generate IOP oscillations that simulated the ocular pulse
found in vivo. Moreover, an additional real-time pressure transducer was located in
parallel to the original pressure transducer to monitor and adjust peak-to-peak mag-
nitude of intraocular pulsations. This improvement allowed researchers to study not
only how a static increase in IOP can affect outflow tissues, but also the effect of cyclic
or dynamic stresses applied to these tissues. In addition, the use of this model demon-
strated that, despite physiological and anatomic differences that exist among species,
porcine and human anterior segments show similar behaviour in response to cyclic
biomechanical stress (Ramos & Stamer 2008).
FIGURE 2.9: Schematic diagram of the anterior pulsatile perfusion
model introduced by Ramos & Stamer (2008). It was a modified ver-
sion of the anterior segment perfusion system introduced by Johnson
and Tschumper (1987). A positive piston displacement pump was used
in combination with a syringe pump to generate IOP oscillations that
simulated the ocular pulse found in vivo. Figure redrawn by the au-
thors.
However, the main drawback of these systems is that the only site of egress for the
perfusate is the trabecular meshwork and the canal of Schlemm. Therefore, the hy-
drostatic pressure in this system varies with the facility of outflow, leading to vari-
able and often elevated IOP (Johnson 1997). Brunette et al. solved this issue in 1989,
adding an outflow cannula that allows a constant level of pressure in the anterior
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chamber (Brunette et al. 1989). With this model, endothelial cells on isolated corneas
were maintained in a viable and functional state for three weeks, but no epithelial
irrigation and evaluation was carried out, making it impossible to study epithelial
restoration following corneal wounding.
2.3.3 Corneal wound healing model(s)
Corneal wound healing is indeed a significant clinical issue as it an essential prerequi-
site for restoring corneal integrity andmaintaining vision after eye injury (Ljubimov &
Saghizadeh 2015), which is the most common reason for attendance at an emergency
department, accounting for 14% of eye department presentations and 8% of eye de-
partment hospitalisations (Nash & Margo 1998).
This phenomenonwas initially studied in submerged organ culture models, which ex-
perienced a reduction in epithelial cell layers, epithelial and stromal oedema together
with endothelial and stromal keratocytes deterioration (Vanhorn et al. 1975, Richard
et al. 1991). Successively, the air interface organ culture technique was developed and
showed to be a more appropriate model for the long-term maintenance of epithelial
integrity (Elgebaly et al. 1984, 1987). In fact, using different animal cornea, several
types of wounds were studied using this technique, frommechanical (Tanelian & Bisla
1992, Carrington et al. 2006) to alkali burns (Zhao et al. 2009). However, since animals
heal differently from humans, researchers have applied this technique to human tis-
sue during the last 25 years (Collin et al. 1995, Foreman et al. 1996, Zagon et al. 2001,
Rajan et al. 2005), more faithfully assessing the role of growth factors in corneal wound
healing. Of relevance, Foreman et al. showed in 1996 that an ex-vivo human corneal
model could be used to evaluate epithelial wound healing over a period of 72 hours
(Foreman et al. 1996). In detail, wounded human corneas were placed in tissue cul-
ture dishes, kept in place by an agar gel and cultured at 37◦C in a humidified 5% CO2
incubator. Moreover, epithelial irrigation was simulated by adding medium dropwise
to the surface of the corneal epithelium every 12hr (Figure 2.10).
Six years later, Janin-Manificat et al. extended this model through the use of additional
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FIGURE 2.10: Schematic diagram of the organ culture model intro-
duced by Foreman et al. (1996). Wounded corneas were placed
epithelial-side down into sterile cups containing tissue culturemedium.
The endothelial corneal concavity was filled with medium containing
agar and rat tail tendon collagen. After the mixture set, corneas were
inverted and transferred to 60 mm tissue culture dishes and cultured
in an incubator with tissue culture medium. Figure redrawn by the au-
thors.
wound healing biomarkers and reporting, for the first time, the opacity that is charac-
teristic of corneal scarring or haze (Janin-Manificat et al. 2012). A further improvement
wasmade by Deshpande et al. in 2015 with the introduction of intermittent movement
of medium on the epithelium (Figure 2.11). By using this model, researchers found a
longer surviving period of the cornea of four weeks and also a more effective recovery
from wounding compared to previous authors (Deshpande et al. 2015).
Although fairly simple to set up andwith a long life span, thesemodels failed tomimic
the situation in vivo in which the cornea is both kept intermittently moist, through the
blinking action of the eyelids, and independently perfused at a physiological flow rate.
A more sophisticated system with separate epithelial irrigation and endothelial per-
fusion was developed by Thiel et al. in 2001. They horizontally mounted porcine
corneoscleral preparations in simple chambers ensuring an air interface on the epithe-
lial side and a fluid perfusion on the endothelial side. By using specular microscopy,
pachymetry and histological techniques, they maintained the tissue physiologically
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FIGURE 2.11: Schematic diagram of the corneal organ culture intro-
duced by Deshpande et al. (2015). Corneas were placed at the periph-
ery of a 90-mm Petri dish and cultured with culture medium. The Petri
dish was placed on a rocking system consisting of an egg incubator,
which was subsequently placed on a platform rocker. Figure redrawn
by the authors.
stable for 14 hours (Thiel et al. 2001). This time frame was limited by the fact that the
epithelial irrigation was performed manually. Zhao et al. overcame this limitation in
2006 introducing a perfusion chamber model made of polycarbonate and securedwith
a clamping sleeve (Figure 2.12), with separate endothelium perfusion and automatic
apical surface irrigation systems (Zhao et al. 2006). They evaluated bovine corneoscle-
ral preparations at light ultrastructural level (corneal cell types, including the putative
epithelial stem cell population), and they monitored epithelial wound healing and re-
sponse to penetrating keratoplasty over a period of 10 days.
The most advanced corneal storage method found in the literature was designed in
2017 by Guindolet et al. using porcine corneas (Guindolet et al. 2017). Their corneal
bioreactor featured distinct epithelial and endothelial controlled chambers. Minimum
essential medium containing 2% FBS was perfused in the endothelial chamber at a
rate of 5 µl/min, while creating an IOP of 20 mmHg. Epithelium was instead alter-
nating exposed to air and immersed in a specific epithelial culture medium using a
controlled peristaltic pump. The whole system was designed to be compatible with
current ophthalmology imaging systems, such as slit lamp, OCT systems and specular
microscopy, and to be fitted in a CO2 incubator (Figure 2.13). The authors were able
to store porcine corneas for seven days, retaining excellent endothelial cell survival,
integrity of the epithelium and limbus, and physiological corneal thickness and shape
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FIGURE 2.12: Schematic diagram of the corneal perfusion chamber in-
troduced by Zhao et al. (2006). It consisted of a perfusion chamber
made of polycarbonate, secured with a clamping sleeve. The scleral re-
gion of the corneoscleral button was clamped between the main body
of the perfusion chamber and clamping sleeve. The endothelium was
perfused at 2.5 µl/min under an IOP of 18 mmHg. The epithelium was
automatically irrigated using an automatic peristaltic pump. Figure re-
drawn by the authors.
never previously achieved.
This innovative bioreactor enabled direct tissue visualisation through its anterior and
posterior transparent windows. However, the mechanical design of the chamber and
the presence of the front window would not allow corneal manipulation to perfect
donor tissue preparation methods for corneal transplant or to practice surgical tech-
niques.
In respect to this, several artificial anterior chambers have been developed along the
years to perfect cataract transplant and lamellar surgery and they have been included
in this review to help determining how complete anterior eye models might be opti-
mised to access and manipulate the ocular structures.
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FIGURE 2.13: Schematic diagram of the corneal bioreactor introduced
by Guindolet et al. (2017). Fresh endothelial medium was pumped into
the anterior chamber using a peristaltic pump controlled by a pressure
sensor and a micro solenoid valve. Epithelial medium was indipen-
detly pumped on the ocular surface every 30s using a separate peri-
staltic pump. Figure redrawn by the authors.
2.3.4 Artificial anterior chamber(s)
The artificial anterior chamber was initially developed by Ward and Nesburn in 1976,
when they introduced a new technique for anterior trephination of corneas preserved
in McCarcy-Kaufman medium (Ward & Nesburn 1976). The ingenious artificial an-
terior chamber was manufactured with Teflon and stainless steel; its main working
components were a black Teflon dome with a flattened top and a stainless steel secur-
ing rings. Using this model, researchers were able to eliminate the need to trephine
excised corneas from the endothelial side when preparing donor buttons for use in
penetrating keratoplasty.
Four years later, this instrument was modified to allow corneoscleral rims to be cut us-
ing a microkeratome (Maguen et al. 1980). However, fears about microkeratome use
hindered the widespread use and development of this device, which became an effec-
tive tool in corneal transplants only after the development of new refractive surgery
techniques such as laser in situ keratomileusis (LASIK) (Pallikaris et al. 1990, Buratto
et al. 1992).
In fact, in the first years of the 21st century Behrens et al. evaluated the precision and
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accuracy of a new artificial anterior chamber model with a metal base in obtaining
corneal lenticules for lamellar keratoplasty (Behrens et al. 2001). The device consisted
of a stainless steel structure with three screw-type safety rings. The lower ring held
a metal device that covered the superficial sclera and maintained a tight fit on the
metal base of the chamber to avoid leakage. A second ring in an intermediate po-
sition approximated the chamber on the former structure to tighten the sclera from
above. Finally, a third ring located superiorly was adjusted to modify the height of
the microkeratome plate. The chamber was also connected to an infusion system with
a reservoir of saline solution, placed 1.2 m above the chamber level to control IOP.
From then on, several authors have used these chambers to mount donor tissue and
perfect techniques such as corneal transplant and penetrating, lamellar and endothe-
lial surgery (Azar et al. 2001, Hamaoui et al. 2001, Li, Behrens, Sweet, Osann & Chuck
2002, Li, Ellis, Behrens, Sweet & Chuck 2002, Springs et al. 2002, Wiley et al. 2002,
Behrens et al. 2003, Busin 2003, Erb et al. 2004, Ignacio et al. 2005, Sarayba et al. 2005,
Ignacio et al. 2006, Pirouzmanesh et al. 2006, Zhu et al. 2006, Bahar et al. 2007).
A further improvement of this technology was made by Bower and Rocha in 2007,
with the introduction of the first disposable artificial anterior chamber (Bower &Rocha
2007). It was composed of three pieces: base with tissue pedestal, tissue retainer, and
locking ring (Figure 2.14). The base had two ports with silicone tubing that can be used
by the surgeon to adjust the pressure injecting or aspirating medium. The Barron ar-
tificial anterior chamber, together with the Moria automated lamellar therapeutic ker-
atoplasty system, the Baush and Lomb artificial anterior chamber and the AMADEUS
artificial anterior chamber have been extensively used to date, reducing the need to
use whole cadaver eyes as surgeons have been given the possibility to use eye bank
corneas rather than whole eyes for lamellar dissections (Kaiserman et al. 2007, Sider-
oudi et al. 2007, Romppainen et al. 2007, Bahar et al. 2008, Mehta et al. 2008, Wu & Yeh
2008, McCauley et al. 2009, Moshirfar et al. 2009, Hwang & Kim 2009, Espana et al.
2011, Krabcova et al. 2011, Rice et al. 2011, Rocha et al. 2011, Sikder et al. 2011, Gatell
2012, Hong et al. 2012, Bhogal et al. 2012, Maier et al. 2012, Tang et al. 2012, Vetter et al.
2012, Bucher et al. 2013, Muraine et al. 2013, Neuburger et al. 2013, Waite et al. 2013,
Arafat et al. 2014, Tsatsos 2014, Vaddavalli et al. 2014, Romano et al. 2015, Villarrubia
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& Cano-Ortiz 2015, Sharma et al. 2016).
FIGURE 2.14: Schematic diagram of the Barron artificial anterior cham-
ber, Bower & Rocha (2007). The corneoscleral button was placed onto
the base, the tissue retainer was carefully placed over the unit and ad-
vanced to the bottom of the base. The artificial anterior chamber was
then secured by placing the locking ring over the unit and turning it
until the locked position is reached. The pressure inside the chamber
was controlled using a gravity infusion system. Figure redrawn by the
authors.
Artificial anterior chambers have greatly contributed to the refinement of corneal trans-
plantation, which is now established as the most successful form of human transplan-
tation (Crawford et al. 2013). Consequently, in a complete anterior eye model corneal
tissue should be easily accessible while the specimen is cultured. On the same note,
millions of individuals worldwide are visually impaired due to cataract formation,
which is the reason why cataract is a major priority in the global initiative to elim-
inate avoidable blindness by the year 2020 (Rao et al. 2011). Today, cataract is only
treated by surgery, which initially restores high quality vision, but then Posterior Cap-
sule Opacification (PCO) develops in a proportion of patients causing a secondary loss
of vision (Wormstone et al. 2009). Unfortunately, the biological processes governing
PCO formation and how surgical procedures can be developed to improve surgery
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outcomes are still unclear. In addition, presbyopia is a ubiquitous concern, which cur-
rently affects more than a billion adults worldwide, and this figure is set to rise as over
40% of the global population are expected to be over 40 years of age by 2030 (Frick
et al. 2015). Despite over a century of investigation, no physical or pharmacological
solution is currently available, since the mechanism of ocular accommodation has not
been fully replicated/mimicked. This is mainly due to the fact that the restorative
techniques are difficult to develop and refine in in vivo models, which provide real
data on ocular physiology, but also restrict the ability to measure dynamic intraoc-
ular forces and morphometric changes with optimal precision. Therefore, scientists
over the past 20-30 years have been developing experimental crystalline lens models
that could be used as meaningful tools to improve patient health (Wormstone & El-
dred 2016), and they have been included in this review to explore the possibility of
combining them with corneal analogues to produce a complete anterior eye model.
2.3.5 Crystalline lens model(s)
Cleary et al. described an in-vitro organ culture model for PCO in which the mean
time to lens epithelial cell (LEC) confluence was 10 days (Cleary et al. 2010). They
introduced a modified dissection technique which retained the ciliary body and zonu-
las fibres in association with the capsular bag by pinning the intact crystalline lens -
zonule - ciliary body complex to a silicone ring. After performing cataract extraction,
the capsule bag was placed in culture and LEC growth was observed along the days
with phase contrast microscopy. However, no mechanical test was performed on the
lens tissue to test accommodation.
The most used methods for elasticity measurements on ex-vivo lenses are compres-
sion techniques (Baradia et al. 2010, Sharma et al. 2011) spinning tests (Fisher 1971,
Schumacher et al. 2009), or stretching devices (Fisher 1977). The first two methods ex-
ert forces on isolated lenses by indenters or by inducing centrifugal forces, while the
stretching device exerts radial forces on the lens via the ciliary body, partly replicating
the dynamic in vivo action of ocular accommodation. This is accomplished by uni-
formly increasing the distance of radially arranged arms, to which the ciliary body or
sclera is attached. Such a stretching device was introduced for the first time by Fisher
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(1977), who measured a decreasing accommodation amplitude of human lenses with
age. Thereafter, several groups improved the device, being able to measure an always
more complete set of lens parameters, including applied forces, optical power, lens
thickness, lens diameter, and radius of curvature, Figure 2.15 (Pierscionek 1993, 1995,
Manns et al. 2007, Ehrmann et al. 2008, Reilly et al. 2008, 2009, Kammel et al. 2012).
Among these parameters, measuring the applied forces represented a key step for-
ward, as the increase in arm distance is only an indirect measure for the actual force
on the ciliary body.
Finally, in 2013, Eppig et al. successfully implanted an accommodative intraocu-
lar lens (IOL) into freshly enucleated porcine eyes mounted in a custom-made lens
stretcher (Eppig et al. 2013). Using OCT imaging, they were able to measure the ac-
commodative vault and change in geometry only in eyes with an intact vitreous, indi-
cating the importance of the latter for the functionality of accommodative IOLs.
FIGURE 2.15: Schematic diagram of a lens stretcher. After preparing the
external ocular surfaces, the tissue is placed in a temperature controlled
cell containing buffered solution. Eight PMMA connectors are bonded
to the tissue and used to stretch the lens to replicate accommodative
action.
2.4 Discussion
Every year, up to 100 million animals are used in laboratory experiments all over the
world; in 2010, the total number of animals used in the United States was almost 1.37
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million, without including rats and mice that make up about 90% of research animals,
but are not covered by the Animal Welfare Act (Shafaie et al. 2016). In 2011, 3.71
million animals were used for research in UK (Doke & Dhawale 2015). To minimise
animal experiments, a great amount of research has been dedicated to the develop-
ment of more economic and ethical alternatives to animal testing, endeavouring to
devise ex-vivo and in-vitro models that could reduce the dependency on live animal
testing. In the ophthalmic field, the development of alternative ex-vivo ocular models
has made important contributions to fundamental applied and preclinical research.
However, ex-vivo storage of ocular tissues in their physiological state still remains a
great challenge for both researchers and eye banks (Guindolet et al. 2017).
This review analysed and compared the most successful ex-vivo ocular surface models
developed mainly in the past 150 years, in order to deduce the most appropriate pa-
rameters that allow physiological eye conditions to be replicated as closely as possible.
A successful ocular storage method should maintain the integrity of every structure of
the ocular surface and their close interrelationship. Moreover, when studying patholo-
gies such as DED, the operational time frame should also be long enough to be able to
evaluate epithelial and endothelial wound healing, and to retain corneal transparency.
As evident in the first ex-vivo model of DED demonstrated by Choy and colleagues,
whole eyeballs have a limited time frame of few hours due to the high mortality rate
of cells (Choy, Cho, Benzie, Choy & To 2004). Organ culture of corneoscleral prepara-
tions should therefore be the preferred choice to expand the usable time scale of the
experimental system.
An additional prerequisite for developing a successful ocular model is the preserva-
tion of physiologically stable epithelium and endothelium to take account of the in-
direct interactions between these two layers (Pai & Glasgow 2010). To preserve the
epithelium, the replication of both in vivo air-liquid interface and tear film dynamics
is crucial. It has been shown that the air-liquid interface improves epithelial integrity
and tight junction formation (Ban et al. 2003), and blinking plays a key role in main-
taining the integrity of ocular surface. Mimicking tear replenishment in the eye re-
quires the delivery of a tear analogue to the surface of the ex-vivo eye model followed
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by a period of drying in a recurring fashion under physiological conditions. In the
past, this has been achieved using either rocking platforms to create an intermittent
movement of cell medium on the epithelium (Deshpande et al. 2015) or automated
systems to drop fluid onto the cornea (Zhao et al. 2006). Recently, Mohammadi et al.
proposed a tear replenishment spray system that allows to cover the corneal surface
with a small amount of tear analogue that is sufficient for hydration while it still main-
tains the air-liquid interface (Mohammadi et al. 2014). By controlling parameters such
as spray frequency and/or tear volume, pathologies such as DED could also be mim-
icked, as decreased blink rate can be associated with the occurrence of its symptoms
(Freudenthaler et al. 2003). In addition, tear analogues should be chemically optimised
for ensuring an epithelial closure rate comparable to that of clinical observations (Dua
& Forrester 1987, Le Sage et al. 2001). Zhao et al. reported epithelial closure rate in
bovine corneas comparable to that of clinical observations of healing in human cornea
when the epithelial surface was irrigated with Hanks MEM containing 4% FBS at a
flow rate of 20 µl/min (Zhao et al. 2006). More recently, Guindolet et at. reinforced
this result showing that intermittent air exposure of the epithelium enabled preserva-
tion of a stratified and differentiated epithelial layer, guaranteeing also the presence
of undifferentiated basal cells expressing stem cell markers (Guindolet et al. 2017).
To preserve the endothelium, the anterior chamber should be distinctly perfused at a
physiological flow rate of ~2.5 µl/min (McLaren et al. 2003) and at a controlled tem-
perature of ~37◦C, creating a pressure 18-20 mmHg higher than atmospheric pressure
in the artificial anterior chamber. To ensure constant flow rates and IOP, the model
should be engineered to have an inflow and outflow cannula for the endothelial per-
fusion, to not leave the TM/Schlemms canal as the only site of egress. Moreover, the
chemical composition of the endothelium perfusate should be optimised for ensuring
endothelial cells preservation and wound healing. Ideally, the medium composition
should be equivalent to that of the aqueous humour as regards concentrations of or-
ganic and inorganic components. Table 2.6 compares the chemical composition of hu-
man aqueous humour, vitreous humour and different media. While BR solution has
been reported to be inadequate for maintaining corneal thickness during in-vitro per-
fusion (Mishima &Kudo 1967), MEM containing 2-4% FBS has shown excellent results
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TABLE 2.6: Chemical composition of human aqueous humour, vitreous
humour, Lactated Ringer’s Solution (LR), Balanced Salt Solution (BSS),
BSS Plus and Minimal Essential Medium (MEM).
Ingredient HAH HVH LR BSS BSS Plus MEM
Sodium 162.9 144 102 155.7 160 143.43
Potassium 2.2-3.9 5.5 4 10.1 5 5.33
Calcium 1.8 144 3 3.3 1 1.79
Magnesium 1.1 1.3 / 1.5 1 0.81
Chloride 131.6 177 / 128.9 130 124.36
Bicarbonate 20.15 15 / / 25 26.19
Phosphate 0.62 0.4 / / 3 1.01
Lactate 2.5 144 28 / / 123
Glucose 2.7-3.7 3.4 / / 5.0 5.55
Ascorbate 1.06 2 / / / /
Glutathione 0.0019 / / / 0.3 /
Citrate / / / 5.8 / /
Acetate / / / 28.6 / /
pH 7.38 / 6-7.2 7.6 7.4 123
Osmolarity (mOsm/Kg) 304 / 277 298 305 280-320
in bovine corneas in term of corneal swelling, without causing any endothelial prolif-
eration (Zhao et al. 2006, Guindolet et al. 2017). Furthermore, the addition of porcine
or human aqueous humour to the anterior perfused segment could improve trabecu-
lar cell viability and molecular characteristics maintenance (Fautsch et al. 2005).
The overall system should be designed to maintain a sterile closed environment and
to be compatible with current ophthalmology imaging systems (such as optical co-
herence tomography, slit lamp, confocal microscope), and the biological tissue used
should ideally be cheaply and readily available. While human material for research is
dramatically declining (Curcio & Research Tissue Acquisition Working 2006), porcine
eyes represent the best substitute for a reliable and high quality tissue source not only
with respect to morphologic and biochemical conditions, but also because the vari-
ations in age compared with human donor eyes are relatively small (Menduni et al.
2018). Moreover, porcine eyes are discarded from food-industry animals, avoiding
the deliberate sacrifice of animals and allowing biochemical and molecular analyses
of samples to be performed in adequate statistical extents.
In conclusion, successful ex-vivo models of the ocular surface are largely the result of
ideas, experimentation and perseverance by researchers over the past approximately
150 years. Nowadays, it is possible to restore a near physiological environment to the
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FIGURE 2.16: Historical evolution of the anterior eye modelling life
span: Grant (1963), Dikstein & Maurice (1972), Foreman et al. (1996),
Guindolet et al. (2017).
cornea or the crystalline lens for up to seven days (Figure 2.16). Though still leaving
room for improvement, these models represent cost-effective platforms for preclinical
experiments, which are suited for studying irritation, permeation and healing in ante-
rior eye ocular structures independently. The development of a complete anterior eye
model, in which the corneal and crystalline lens tissue could be maintained physio-
logically stable for several days in their natural anatomy may represent a natural step
forward for the scientific community. Due to the greater availability of immunoas-
says and imaging techniques, this model could allow researchers to create a powerful
testing platform to elucidate problematics such as the complex relationship between
cataract surgery and DED, as well as fostering the creation of an artificial or bioengi-
neered cornea, holy grail of corneal transplantation.
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Optimisation of the Porcine Tissue Sample
for Biomedical Research
3.1 Introduction
In the ophthalmic field, the ex-vivo storage of the biological tissue in its physiological
state is one of the greatest challenge of both eye bankers and researchers. The pig
cornea is the most suitable corneal xenograft due to the considerable similarity to hu-
man corneas in terms of refractive power, size and tensile strength (Kim et al. 2016).
In addition, porcine tissue can be collected from local abattoirs and used immediately
post mortem for preclinical tests, allowing vision science researchers to perform sev-
eral experiments at reduced cost (Menduni et al. 2018).
In theory, porcine tissue samples represent thus an unlimited research resource, but
in practice porcine corneas in organ culture although remaining metabolically and
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physiologically active, they lose their shape and transparency and dramatically swell,
becoming more than four times ticker and greatly affecting the outcome of research
studies (Guindolet et al. 2017). Even if porcine corneal products have been classified
as suitable for human clinical trials when processed by standard procedures recom-
mended by the European Eye BankAssociation (EEBA) guidelines for technical prepa-
ration of the cornea, the translation of the scientific findings is very dependent on the
eyeball quality and storage conditions (Kim et al. 2014). Therefore, it is crucial to op-
timise the preservation technique of porcine eyes to maximise corneal transparency
and minimise tissue deterioration.
This chapter evaluated the optimal preservation technique for porcine eyes in respect
to corneal transparency and tissue deterioration combining invasive and non-invasive
characterisation techniques of biological tissue.
3.2 Methods
Ten porcine eyeballs were enucleated from a local abattoir within four hours of animal
death and transferred to the laboratory either in air or in the transport solution at 4◦C
(Figure 3.1). The transport solution consisted of Dulbeccos Modified Eagles Medium
(DMEM; Lonza, Berkshire, UK), supplemented with 1% penicillin (10,000 units/ml)
and streptomycin (10,000 mg/ml), 1% v/v L-glutamine (Lonza, Berkshire, UK), 10%
Foetal Bovine Serum (FBS; Sigma-Aldrich, UK) and 20%w/v Dextran (Mw ∼ 250kDa,
Sigma-Aldrich, UK) to minimise corneal swelling. Animals were white domestic pigs
aged between 12 to 25 weeks.
Central corneal thicknesswas obtained using ultrasound pachymetry (UP-1000, Nidek,
Gamagori, Aichi, Japan), while corneal and crystalline lens transparency were quanti-
fied using spectrophotometry (SpectraMax M2, Molecular Devices, LLC). In addition,
dynamic mechanical analysis (DMA) was performed to evaluate viscoelastic proper-
ties of two corneas using a shear rate and yield stress rheometer (Bohlin CVO,Malvern
Instruments LTD, UK). All measurements were obtained within 36-hour after enu-
cleation (Figure 3.2), and for measurements performed 24 hours and 36 hours after
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(A) (B)
(C)
FIGURE 3.1: Enucleation of the porcine eyeball (A), and its transporta-
tion in supplemented storage solution (B) and air (C).
enucleation, eyes were stored at 4◦ C either in air or in the transport solution.
A crucial drawback of the spectrophotometry and DMA is that they require harvest-
ing replicate samples at specific time points for evaluating tissue quality. Laser flu-
orescence spectroscopy (LFS) is currently one of the most promising methods for a
non-invasive characterisation of biological tissue, especially in the oncologic field, as
it allows to measure the dynamics of metabolism without the need to take biopsies
(Rogatkin et al. 1998).
The LAKK-M system is a multifunctional non-invasive laser diagnostic instrument
that, when used in its Fluorescence operation regime, evaluates tissue fluorescent
biomarkers by measuring the endogenous tissue fluorescence induced by external
laser irradiation (Figure 3.3). For excitation of fluorescence biomarkers, this system
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(A) (B)
FIGURE 3.2: Exemplary pictures of ultrasonic pachymetry measure-
ments performed on porcine eyeball.
is equipped with fibre optic probe and uses laser sources with three wavelengths: 365
nm (UV), 532 nm (Green) and 630 nm (Red). This allows estimation of fluorescence
radiation intensity for nicotinamides, flavin, lipofuscin, porphyrin and other fluoresc-
ing biomolecules (Raznitsyna et al. 2018).
FIGURE 3.3: Exterior view of the LAKK-M system, which includes a di-
agnostics block for data processing, a light-guide cable, a pulse oxime-
ter and calibrated light filters.
Therefore, thirteen freshly enucleated porcine eyes were transported to the laboratory
in the transport solution and analysed via LAKK-M system within 6 hours after enu-
cleation to investigate the viability of detecting corneal deterioration while avoiding
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tissue sacrifice (Figure 3.4).
FIGURE 3.4: Experimental setup of LFS on porcine eyeballs.
Spectroscopic data were analysed using Matlab software (The Mathworks, Inc., Nat-
ick, MA).
3.3 Results
The corneal tissue transparency was influenced by both the freshness of the eyeball
and the storage conditions. The critical factor appears to be the freshness and qual-
ity of the eye at collection as any of the transport methods used was able to restore
transparency in cloudy eyes (Figure 3.5). However, using supplemented DMEMwith-
out Phenol Red as transport solution reduced corneal turgidity thereby maintaining
corneal thickness and transparency up to 36 hours after enucleation, and avoiding
pink colouring of the cornea (Figure 3.6).
The use of spectral transmission represented a further way to assess both the corneal
and crystalline lens tissue. As showed in Figure 3.7, transparent corneas were char-
acterised by an average percentage of light transmission 2.11x higher than cloudy
corneas up to 36 hours after enucleation and independently from the storage method
applied. On the other side, crystalline lenses were less influenced by the storage con-
ditions due to the protection of the eyeball, and lenses with un-intact capsule showed
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(A) (B)
FIGURE 3.5: Exemplary pictures of porcine eyes immediately after enu-
cleation (A), and corneas after dissection (B). Eyeballs may be already
cloudy after enucleation and the use of DMEM containing Phenol Red
as transport solution turned corneas pink.
a characteristic drop in transmission between 200 and 300 nm.
(A) (B)
FIGURE 3.6: Effect of initial storage on corneal thickness (A), and effect
of storage over time on corneal thickness (B). Storing eyes in supple-
mented DMEMminimised changes in corneal thickness over 36 hours.
In terms of viscoelastic properties, the two corneas tested using DMA retained both
their dynamic elastic modulus G and dynamic viscous modulus G after storage in
supplemented DMEM for 36 hours (Figure 3.8), suggesting that this may be another
useful tool to use for assessment of ocular tissue properties.
Spectroscopic data obtainined via the LAKK-M system are reported in Figure 2.9.
Transparent corneas were characterised by lower UV backscatter and greater fluores-
cence signals associated with elastin, NADH and pyridoxine than cloudy corneas.
In particular, themost transparent eye showed a backscattered signal 4.88x less intense
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(A)
(B)
FIGURE 3.7: Transmission spectra of six porcine corneas (A) and four
porcine crystalline lenses (B). Transparent corneas showed higher trans-
mission than cloudy corneas. Un-intact crystalline lenses were charac-
terised by a change in transmission between 200 and 300 nm.
than the cloudiest cornea (Figure 3.10), while being characterised by more intense flu-
orescent signals of elastin (+97.8%) and NADH (+94.8%), as shown in Figure 3.11.
Due to the uncertainty of the results of such measurements, which may amount up to
40% of the measured value (Rogatkin et al. 1998), the experimentally observed differ-
ences between LFS signals from transparent and cloudy corneas were significant for
the backscatter, the elastin and the NADH, but not for the collagen and the pyridoxine.
3.4 Discussion
A local abattoir could serve as a source of reliable, high quality biological tissue for ex-
vivo anterior eye models. Pig eyes are an attractive model for research and xenotrans-
plantation due their low costs and close correlation with human anatomy (Loewen
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FIGURE 3.8: Dynamic mechanical traces of two porcine corneas pre and
post storage in supplemented DMEM for 36 hours.
(A) (B)
FIGURE 3.9: Spectroscopic data of 13 porcine eyes analysed using
LAKK-M system (A). Spectroscopic data of the most transparent and
most opaque eye, and associated biomarkers (B).
et al. 2016). However, the reproducibility of the scientific findings derived from ex-
vivo models based on porcine eyes is strongly dependent on the eyeball quality and
storage procedure.
This chapter highlighted that the condition of the eyeball at the enucleation dictates
the performance of the biological tissue in experimental tests. Porcine eyeballs should
be collected fresh and only transparent corneas should be further processed for exam-
ination up to 36 hours after enucleation. The suggested time frame of 36 hours takes
also into account the viability of LECs, which has been previously shown to be of 50
hours when porcine eyeballs are simply stored at 4◦C in tap water (Nibourg & Koop-
mans 2014).
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(A) (B)
(C)
FIGURE 3.10: Peak of the backscattered signal received from the 13
porcine corneas analysed using LAKK-M system. Picture of the cloud-
iest (A) and most transparent (B) cornea analysed.
Tissue transportation should be carried out at 4◦C to attenuate cellular metabolism,
and using DMEM based solutions supplemented with hydrophilic macromolecules
that produces colloid osmotic pressure to extract excess water accumulated in the
stroma and, therefore, reduce corneal swelling (Zhao et al. 2012, Dias & Ziebarth 2015).
In addition, it would be preferable to use cell medium which does not contain Phenol
Red as it turns corneas pink, possibly influencing study outcome depending on the
type of testing.
Corneal transparency can be evaluated using spectrophotometry, however, here it has
also been demonstrated the viability of using laser fluorescence spectroscopy to quan-
tify transparency throughout the culture period avoiding tissue sacrificing. Due to
the possibility of measuring porphyrins with LFS, this technique may also be used for
the diagnosis of a local inflammation in corneal tissues in DED research, as one of the
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(A) (B)
(C) (D)
FIGURE 3.11: Fluorescent peaks of different biomarkers in 13 porcine
corneas. A (Collagen), B (Elastin), C (NADH), D (Pyridoxine).
reason of the enhanced accumulation of porphyrins in tissues is chronic hypoxia (Ro-
gatkin et al. 2009).
In an abattoir, all pig carcasses undergo a scalding process immediately post-mortem
to remove hair and reduce skin-dwelling bacterial contamination (Bolton et al. 2003).
In particular, pig carcasses are immersed in a scald tank containing water heated to ∼
65◦C for removing remaining bristles from the hair follicles. During this process pig
eyelids usually remain open, exposing the anterior surface of the cornea to a possible
thermal injury that leads to a clear physical disruption and loss of the corneal epithe-
lium from the underlying stroma (Chinnery et al. 2005).
During the last part of this PhD project, a business relationship was established with
an abattoir, which allowed eye enucleation to be performed before the scalding proce-
dure. Four eyes were obtained, photographed and stained with fluorescein to analyse
epithelial corneal damage. Preliminary results showed that pre-scalded eyes were
characterised by superior transparency and a perfectly intact corneal epithelium (Fig-
ure 3.12). Therefore, pre-scalded porcine eyes should be used when corneal integrity
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is a crucial aspect of the research project.
(A) (B)
(C)
FIGURE 3.12: Pre-scalded eye (A). Fluorescein staining of an intact
corneal epithelium of a pre-scolded eye (B). Corneal epithelial fluores-
cein staining after inducing injury (C).
In conclusion, this chapter provides initial guidelines on optimal storage of porcine
tissue samples for their use in biomedical research. Using pre-scalded eyes and adopt-
ing standard handling and storing procedures would result in higher consistency and
reproducibility of experimental results obtained using ex-vivo porcine ocular models,
dramatically improving the effectiveness of those cost-effective preclinical platforms.
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Anatomical Biometry of the Porcine Eyeball
4.1 Introduction
The use of animals in biomedical research is a longstanding practice beginning in an-
cient Greece, when Alcmaeon of Croton determined that the brain is the seat of intel-
ligence and sensory integration by studying dogs (Ericsson et al. 2013). In the oph-
thalmic field, in-vivo animal models have been used for many years to evaluate how
visionwas evolved and to study the pathophysiologic mechanisms causing ocular dis-
eases (Chader 2002). In DED research, many animal models have been developed to
mimic the multiplicity of mechanisms underlying the pathology and to explore treat-
ment options, however none of them seems to precisely mirror the complexity and
chronicity of this disease (Barabino & Dana 2004).
While the mouse remains the most attractive in-vivo animal model of DED due to
the extensive availability of transgenic strains and knockout and specific reagents
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(Beyazyldz et al. 2012), recently the porcine eye has been extensively used as an ex-
vivo animal model due to its proposed similar morphology and tear film to the human
eye (Fyffe et al. 2005, Ruiz-Ederra et al. 2005, Wong et al. 2007, Fernandez-Bueno et al.
2008, Chan et al. 2014, Loewen et al. 2016). In particular, Choy et al. developed a
system in which different levels of severity of dry eye can be mimicked manipulat-
ing blinking rate and tear volume (Choy, Cho, Benzie, Choy & To 2004). Moreover,
porcine lacrimal and meibomian glands have been shown to be similar to humans
(Henker et al. 2013), and the recently sequenced genome of Suf scrofa indicates that
pigs are genetically more similar to humans than mice, further stressing the validity
of this model (Groenen et al. 2012).
In 1997 Bartholomew et al. analysed 25 porcine globes using ultrasound biomicroscopy
(Bartholomew et al. 1997). Since then, further studies have examined some porcine
eye parameters, but, as summarised in Table 4.1 their sample size and the parame-
ters investigated have been limited. In addition, in these studies eyes have generally
been transported dry on ice prior to measurement, which may affect the structural
and physiological integrity of the sample. Therefore, a source of reproducible data
concerning the parameters of the porcine eye, including corneal topography and con-
focal microscopy, is still missing.
The aim of this chapter is to provide an extensive characterisation of the porcine eye-
ball, to help vision scientists to effective use the pig eye as a biomedical model in the
applied ophthalmic research such as dry eye.
4.2 Methods
Sixty porcine eyes were enucleated from a local abattoir around 12:00 noon and trans-
ferred to the laboratory in a transport solution at 4◦C. The transport solution con-
sisted of Dulbeccos Modified Eagles Medium (DMEM; Lonza, Berkshire, UK), sup-
plemented with 1% penicillin (10,000 units/ml) and streptomycin (10,000 mg/ml),
59
Chapter 4. Anatomical Biometry of the Porcine Eyeball
TABLE 4.1: Key aspects of previous studies analysing the porcine eye-
ball parameters. ACD: Anterior chamber depth; HCD: Horizontal
corneal diameter; VCD: Vertical corneal diameter; CCT: Central corneal
thickness; CCP: Central corneal pachymetry; CD: Corneal diameter; Ks:
Steepest meridian; Kf: Flattest meridian.
Author/s Eyes No. Measurement Method Results
(Bartholomew et al. 1997)
Anterior Chamber ACD: 2.21 mm
25 Globe Diameters Ultrasound biomicroscopy HCD:16.61 mm
Corneal Diameters VCD:14.00 mm
(Asejczyk-Widlicka et al. 2008)
12 Anterior Chamber OCT CCT: 0.96± 0.05 mm
12 Scleral thickness ACD: 2.13± 0.22 mm
(Sanchez et al. 2011)
Ks: 41.19± 1.76 D
Keratometric power Keratometry Kf: 38.83± 2.89 D
∆K: 2.36± 1.70 D
5 Corneal Astigmatic power Ultrasound Pachymetry HCD : 14.3± 0.25 mm
VCD : 12.00± 0 mm
Corneal thickness Corneal Topography CCP: 877± 13.58 µm
(Heichel et al. 2016)
Keratometric power Keratometry Ks: 39.6± 0.89 D
Kf: 38.5± 0.92 D
5 Corneal Astigmatic power Corneal Topography ∆K: 1.10± 0.78 D
CCP: 832.6± 40.18 µm
Corneal thickness Ultrasound Pachymetry CD: 13.81± 0.83 µm
1% v/v L-glutamine (Lonza, Berkshire, UK), 10% Foetal Bovine Serum (FBS; Sigma-
Aldrich, UK) and 20% w/v Dextran (Mw ∼ 250kDa, Sigma-Aldrich, UK) to minimise
corneal swelling. Animals were white domestic pigs aged between 12 to 25 weeks. To
avoid tissue deterioration, examinations were performed within 6 hours after enucle-
ation.
Central corneal curvature was measured with E300 Corneal Topographer (Medmont,
Melbourne, Australia). Corneal thickness (central and at 5mm and 9mm eccentricity),
anterior chamber depth and angle were measured with a Visante OCT system (Carl
Zeiss Meditec, Inc, Oberkochen, Germany). Anterior chamber depth was measured
from the posterior corneal surface to the anterior lens, Figure 4.1. Corneal thickness
was also evaluated using an ultrasonic pachymeter (UP-1000, Nidek, Gamagori, Aichi,
Japan). Eyeballs images were taken with a digital slit-lamp (CSO, Firenze, Italy) and
both corneal horizontal and vertical diameter were evaluated using ImageJ software
(https://imagej.nih.gov/ij/).
Corneal endothelial cells are high specialised cells, which do not divide in vivo. En-
dothelial cell density (ECD) is, therefore, a commonly reported indicator of corneal
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FIGURE 4.1: Representative Visante OCT image of an examined porcine
eyeball.
health, as values below ∼ 500 lead to oedema, corneal clouding and eventually vision
loss in humans (Engelmann et al. 2004). A small sample of ten porcine eyes that guar-
anteed the best corneal transparency were used for the determination of ECD, which
was obtained using a scanning slit confocal microscope (ConfoScan 3, Nidek Tech-
nologies, Padova, Italy). Different eyeball holders were specially designed to securely
position samples during imaging and measurements without distorting the natural
structure (Figure 4.2). To prevent dehydration, samples were irrigated with saline so-
lution during the experimental procedure, and experiments were performed at room
temperature.
(A)
(B)
FIGURE 4.2: Setup for scanning slit confocal examination of porcine
eyeballs. Overall measuring configuration (A); porcine eye secured in
the holder (B). Due to the size variability of porcine eyes, the holder
has been designed to fit different globe sizes by adjusting the two top
screws in the right image.
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Statistical analysis was performed using Matlab software (The Mathworks, Inc., Nat-
ick, MA). Kolmogrov Smirnov test was used to determine whether the data were nor-
mally distributed. Data were found to be normally distributed (p > 0.05).
4.3 Results
4.3.1 Corneal curvature
Corneal curvature data are illustrated in Figure 4.3. The average corneal steepest and
flattest meridian were 7.85± 0.32 mm and 8.28± 0.32 mm, respectively, with associ-
ated shape factor (p-value) of 0.38 ± 0.25 and 0.51 ± 0.30 (Benes et al. 2013), and a
mean curvature difference (∆K) of 0.43± 0.18 mm.
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FIGURE 4.3: Steepest meridian data distribution and associated Gaus-
sian fitting (Left); Flattest meridian data distribution and associated
Gaussian fitting (Right).
4.3.2 Corneal thickness
Central corneal thickness, measured with the ultrasonic pachymeter and the Visante
OCT system, were 1009± 1 µm and 1248± 144 µm, respectively. OCT data distribu-
tion is presented in Figure 4.5.
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Porcine Corneal Thickness Distribution - OCT
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FIGURE 4.4: Corneal thickness data distribution (Visante OCT) and as-
sociated Gaussian fitting.
The porcine corneal thickness was relatively constant in the centre and slightly thick-
ened towards the limbus. In particular, the corneal thickness was found to be 2% and
8% thicker at 5 mm and 9 mm from the centre, respectively, in a sample of twenty
eyeballs that guaranteed the best alignment with the instrument, Figure 4.5.
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Porcine Corneal Thickness Profile - OCT
FIGURE 4.5: Porcine corneal thickness profile. The figure shows the
corneal thickness at the centre, at 5 mm and 9 mm in twenty porcine
eyeballs. Error bars = 1 S.D.
4.3.3 Anterior chamber angle and depth
Data distributions relative to anterior chamber angle and depth are shown in Fig-
ure 4.6. The average anterior chamber angle was 28.83 ± 4.16 deg, while the mean
anterior chamber depth was 1.72± 0.26 mm. It has to be noted that the OCT obtains
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the geometrical path measure dividing the optical path length by the refractive index
value of 1.376. Taking into account that the anterior chamber is filled with aqueous
humour, whose refractive index is 1.333, correcting for this discrepancy the mean an-
terior chamber depth was 1.77± 0.27 mm (Podoleanu et al. 2004).
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FIGURE 4.6: Anterior chamber angle data distribution and associated
Gaussian fitting (Left); Anterior chamber depth data distribution and
associated Gaussian fitting (Right).
4.3.4 Corneal diameters
Data related with corneal diameters are reported in Figure 4.7. The average shortest
corneal diameter was 12.69± 0.58 mm, while the mean longest corneal diameter was
14.88± 0.66 mm.
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Porcine Shortest Corneal Diameter Distribution
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Porcine Longest Corneal Diameter Distribution
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FIGURE 4.7: Shortest corneal diameter data distribution and associated
Gaussian fitting (Left); Longest corneal diameter data distribution and
associated Gaussian fitting (Right).
4.3.5 Endothelial cell density (ECD)
The average ECD was 3250± 172 cells/mm2, and an exemplary confocal image of the
porcine corneal endothelial layer is shown in Figure 4.9.
FIGURE 4.8: Representative confocal image of the endothelial cells lay-
ers of an examined porcine eyeball.
4.4 Discussion
Ex-vivo eye models provide economic and logistical advantages for animal alterna-
tives, as they allow faster safety and risk assessment of chemicals/pharmaceuticals,
with a potential greater predictive relevance for human and environmental safety
compared to cumbersome animal-based approaches (Doke&Dhawale 2015). In vision
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science research, the pig eye is one of themost commonly usedmodels, as its morphol-
ogy has been widely investigated (van Vreeswijk & Pameyer 1998, Shentu et al. 2009,
Menduni et al. 2018). However, experimental evaluations of the main parameters of
the porcine eyeball are scarce in literature, especially with regard to corneal topogra-
phy and endothelial imaging.
This chapter investigated several anatomical parameters of the porcine eye, combining
optical mapping, confocal microscopy, ultrasonic pachymetry and OCT. The viability
of using optical mapping systems such as the Medmont E300 Corneal Topographer
was assessed in evaluating porcine corneal topography ex-vivo. An average corneal
steepest and flattest meridian of 7.85± 0.32 mm and 8.28± 0.32 mm were respectively
found, with associated eccentricity (ϵ =
√
(1− p)) of 0.79± 0.17 and 0.70± 0.20, and
with a mean ∆K of 0.43± 0.18 mm. These values are slightly smaller than those re-
ported by Sanchez et al. (8.19 mm and 8.69 mm, ∆K = 0.50 mm) and Heichel et al.
(8.52 mm and 8.77 mm, DeltaK = 0.25 mm), but more closely centred in the range of
human anterior corneal curvature (7.06 to 8.66mm) (Mashige 2013, Sanchez et al. 2011,
Heichel et al. 2016).
This is the first time the shape factor (or rate of flattening of the cornea from the cen-
tre to the periphery) of porcine eyes has been reported. Being greater than humans
(0.41± 0.11), it reflects that the porcine corneal surface is flatter, but both corneal ge-
ometries are elliptical in shape (Benes et al. 2013). These interesting findings suggest
that porcine eyes may also be used as a valuable tool in the research and development
on new contact lens materials (Figure 4.9).
With regards to corneal thickness, it is worth noting that the porcine cornea is char-
acterised by a thicker epithelium and stroma than the human, and lacks Bowmans
layer (Sanchez et al. 2011). Using ultrasonic pachymetry and OCT, a mean corneal
thickness of 1009± 1 µm and 1248± 144 µm were respectively obtained. The former
value is comparable to both the one obtained ex-vivo by Jay et al. using laser scanning
microscopy (1013± 10 µm) (Jay et al. 2008), and the one obtained ex-vivo by Asejczyk-
Widlicka et al. using a Visante OCT (960± 50 µm) (Asejczyk-Widlicka et al. 2008). In
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FIGURE 4.9: Exemplary 3D topography of a porcine cornea.
addition, all in-vitro/ex-vivo study findings are considerably higher than in-vivo find-
ings (666µm) (Faber et al. 2008). This difference may be related with the different ages
and types of pig used, together with potential corneal swelling occurring due to the
time after enucleation ex-vivo measurements are taken. The corneal thickness only
increased slightly in the periphery (1.02x at 5mm eccentricity and 1.08x at 9mm ec-
centricity) so was more similar to the human peripheral cornea (Prospero Ponce et al.
2009).
Furthermore, anterior segment OCT was used to measure anterior chamber angle and
depth, revealing an average anterior chamber angle of 28.83± 4.16 deg, and amean (re-
fractive index corrected) anterior chamber depth of 1.77± 0.27 mm. These values are
smaller than the ones reported in previous studies (Bartholomew et al. 1997, Asejczyk-
Widlicka et al. 2008), which may be accounted for by the mounting or transportation
methods, or by the pig age.
The mean shortest and longest diameter of 12.69mm and 14.88mm found in this study
are in accordance with previous findings in vivo (12.4mm and 14.9mm, respectively)
and ex-vivo (14.00mm and 16.61mm, respectively) (Bartholomew et al. 1997, Faber et al.
2008). These data outline the asymmetrically oval shape of the porcine cornea, also
indicating that standard diameter commercial contact lenses, which have a diameter
of approximately 14mm, would not fit well on a porcine eye.
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TABLE 4.2: Comparison of mean porcine eye parameters experimen-
tally obtained and estimated average human eye parameters according
to the scientific literature.
Parameter Porcine eye Human eye
Corneal steepest meridian 7.85 mm 7.65 mm
Corneal flattest meridian 8.28 mm 7.79 mm
Corneal astigmatism (∆K) 0.43 mm 0.14 mm
Central corneal pachymetry 1009 µm 523 µm
Peripheral corneal thickness (7-9 mm) 1340 µm 564 µm
Anterior chamber depth (OCT) 1.77 mm 3.11 mm
Anterior chamber angle (OCT) 28.8 deg 38.1 deg
Shortest corneal diameter 12.69 mm 11.71 mm
Longest corneal diameter 14.88 mm 12.00 mm
Endothelial cell density (ECD) 3250 cell/mm2 2496.9 - 4049.5 cell/mm2
Finally, a scanning slit confocal system (ConfoScan3, Nidek Technologies, Padova,
Italy) was used to evaluate porcine ECD ex-vivo. A mean ECD of 3250± 172 cell/mm2
was found, which is lower than the ones reported in previous studies (4411 ± 280
cell/mm2) (Kim et al. 2010, Schroeter et al. 2015). The discrepancy may be due to the
different technique used, especially because ConfoScan3 data on porcine eyes were
not found in the literature. The findings of this chapter are, however, within the hu-
man normal range (2496.9 - 4049.5 cell/mm2) assessed using scanning slit confocal
systems (Bourne 2003).
The differences between the porcine eye data obtained in this chapter and correspond-
ing human anterior segment parameters are summarised in Table 4.2, which clearly
shows the really similar morphology to the human eye, key feature that may allow
researcher to conduct reproducible studies on contact lenses and solution cytotoxicity
(Bourne 2003, Rufer et al. 2005, Nemeth et al. 2007, Leung et al. 2008, Prospero Ponce
et al. 2009, Hashemi et al. 2010, Benes et al. 2013, Mashige 2013).
In conclusion, this chapter represents a further source of reproducible data that should
be considered when using porcine eyes as ex-vivo model for experimental research.
The cost and availability of high quality human donor eyes are obstacles to vision sci-
ence research. Porcine eyes, if properly handled and stored, represent a reliable and
high quality tissue source with similar glands producing the tear film that may be
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combined with bioengineering and bio-photonics technologies to provide new useful
tools and models in applied ophthalmic research, in particular in dry and ageing eye
research (Choy et al. 2008, Loewen et al. 2016).
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The Aston Biological Anterior Eye Model
5.1 Introduction
Developing ex-vivo anterior eye models is an intuitive, necessary surrogate to illumi-
nate some of the intricate mechanisms of ocular pathologies such as Dry Eye Disease
(DED) which are challenging to analyse in-vivo (Choy, Cho, Benzie, Choy & To 2004,
Spoler et al. 2010). De facto, ex-vivo organ cultures are becoming increasingly im-
portant in both fundamental and applied biomedical research, as they more closely
retain the natural cellular behaviour found in-vivo than in-vitro monolayer cultures
(Figure 5.1). However, organ culture is extremely challenging, as environmental con-
ditions must be controlled and optimised to maintain tissue viability and stable matrix
composition (Shafaie et al. 2016).
Tissue viability is generally prolongedwhen pseudo physiological conditions are recre-
ated as closely as possible and sufficient levels of supplements are retained at cellular
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FIGURE 5.1: Number of publications per year with the keywords ex
vivo model in the title. There has been an evident increase in the
number of publications related with ex-vivo organ culture from 1995 to
date. Search has been performed on all databases of Web of Science on
September 2018.
level by periodically refreshing the culture medium that eliminates metabolic waste
products from the cellular environment (Elson et al. 2015). Recently, advances in
biomedical technologies have led to the development of bioreactors capable of closely
controlling environmental and operating conditions, such as temperature, pressure,
flow rate and nutrient supply in organotypic models of the cornea and the crystalline
lens, retaining cell viability over seven days (Guindolet et al. 2017, Cleary et al. 2010,
Zhao et al. 2006). As discussed in Chapter 2, these models represent cost-effective
platforms for preclinical experiments, though they still leave room for improvement
toward the creation of a complete anterior eye model that could elucidate the complex
interaction between the different structures of the anterior eye in pathologies such as
DED.
This chapter describes how biomedical technologies such as rapid prototyping and
manufacturing, electronic design, optical imaging and biological assays have been
combined to devise a novel ex-vivo complete anterior eye model that could be a mean-
ingful alternative to animal testing for studying anterior eye physiopathology.
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5.2 The organ storage system
The organ storage system was designed to maintain a sterile closed environment for
the porcine anterior segment that could enable cellular long-term storage. It consisted
of a modular perfusion chamber inserted into an environmentally controlled system
composed by a peristaltic pump-based perfusion system and an automatic irrigation
platform (Figure 5.2).
FIGURE 5.2: Aston organ storage system scheme. The biological spec-
imen is securely clamped in a perfusion chamber, which is connected
to a perfusion system that controls endothelial perfusion flow rate, IOP
and temperature. On the epithelial side, the perfusion chamber is con-
nected to an automated irrigation system controlling epithelial irriga-
tion frequency to replicate air/liquid interphase.
The ocular storage system was design to allow for independent IOP, flow rate and
temperature control in the endothelial compartment, and replication of air/liquid in-
terphase via modulation of irrigation frequency on the epithelial side, as identified in
Chapter 2 as the key features necessary to maintain the eye model.
5.2.1 Modular perfusion chamber
The modular perfusion chamber was designed in SOLIDWORKS 2015 (Dassault Sys-
tems, Vélizy-Villacoublay, France), with the scope to securely clamp and constantly
bathe porcine anterior segments with physiological solution at controlled tempera-
ture, flow rate and pressure.
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The chamber consisted of a Suction module, which was devised to satisfactory cap-
ture the porcine globe at its pre-equatorial region during the dissection procedure, and
a Perfusion module, instead devised to securely clamp the anterior segment creating
a watertight seal, and allow media perfusion to the crystalline lens and corneal en-
dothelium. Both modules were design to be harmoniously adopted into a Mounting
protocol that could allow the operator to dissect the globe and securely mount it for
perfusion in the shortest amount of time possible, minimising tissue deterioration.
Suction module
Initial design concepts were based on the biometric references reviewed in Chapter 4,
and then evolved until the globe equator was easily accessible for dissection and the
whole cornea was visible and irrigable (Figure 5.3). A modular suction chamber was
thus designed to firmly hold the globe during dissection by creating a light vacuum
using a 25ml syringe (Figure 5.4).
(A) (B)
(C) (D)
FIGURE 5.3: Evolution of the prototyping phase of the suction mod-
ule. Sustainability was reinforced minimising the amount of material
used via 3D printing, reducing energy consumption and using local re-
sources.
Due to the interspecies variability of the biological tissue (see Chapter 4), the physical
dimensions of the chamber needed to be optimised to ensure air-tight clamping of
the sample while minimising tissue distortion, which was achieved by iteratively 3D
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printing, laser cutting and trialling several chamber prototypes, prior to construction
of the finalised prototype in biologically inert and autoclavable PTFE (Figure 5.4).
(A) (B)
(C) (D)
FIGURE 5.4: Suction module design and manufacturing. SOLID-
WORKS renderings (A and B). 3D printed prototypes tested (C). Final
suction chamber manufactured in PTFE (D).
Perfusion module
As well as for the suction chamber, initial design concepts of the perfusion module
were based on the biometric references reviewed in Chapter 4, and then the physical
dimensions of the chamber evolved until the porcine tissue could be perfused with-
out significantly altering the morphological structure of the anterior segment. The
final prototype was optimised by having a wall thickness sufficiently large to bear the
sterilisation process without bending and was manufactured in PTFE (Figure 5.5).
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(A) (B)
FIGURE 5.5: Perfusion module design and manufacturing. SOLID-
WORKS renderings (A) and final prototypes manufactured in PTFE (B).
Mounting protocol
The mounting protocol was devised to securely clamp the porcine anterior segment in
the perfusion module within the shortest amount of time possible to minimise tissue
handling (Figure 5.6).
FIGURE 5.6: Schematic description of the procedure devised to mount
a porcine anterior segment in the perfusion chamber.
The procedure was composed by the key steps below:
1. Eyeball holding: the porcine eyeball is placed epithelial side down into the suc-
tion module. A light suction is generated using a 25 ml syringe, consequently
holding the tissue in place;
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2. Globe dissection: the porcine globe is dissected at the equator using a vibrat-
ing blade (PMF 220 CE, Bosch), the posterior segment is discarded, exclusively
leaving in place the anterior segment and relative vitreous;
3. Perfusion chamber mounting: the perfusion module is pressed on the suction
module and attached to it via a rotation mechanism. Tolerances of both modules
have been optimised to allow for smooth components rotation, while still guar-
antying awater-sealed clamping of the porcine anterior segment to the perfusion
chamber;
4. Endothelial perfusion: the suction module is unscrewed, and the perfusion
chamber is connected to both the peristaltic pump and the pressure sensors to
initiate endothelial perfusion and stabilise IOP.
5. Epithelial irrigation: the perfusion chamber is mounted vertically into the au-
tomatic irrigation system and epithelial irrigation is initiated.
The whole procedure is reported in the video footage no 1, which has been supplied
as supplementary data. Combining rapid prototyping with traditional mechanical
manufacturing minimised prototyping time and final chambers allowed the author to
successfully dissect, mount and perfuse more than 95% of the samples.
To further validate the mounting technique, morphometric data regarding anterior
chamber depth (ACD) and central corneal thickness (CCT) were obtained from eight
freshly enucleated porcine eyes using SD-OCT (Ganymede Series SD-OCT, Thorlabs)
before and after dissection /mounting (Figure 5.7). Parameters of the SD-OCT system
used in the study are reported in Table 5.1, while experimental results are detailed in
Table 5.2 and Table 5.3.
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TABLE 5.1: Parameters of the Ganymede Series SD-OCT, Thorlabs.
Central wavelength 930 nm
Axial resolution 5.8 µm (air)
Lateral resolution 8 µm
Sensitivity 101 dB (at 5.5 kHz)
TABLE 5.2: Anterior chamber depth (ACD) measured in eight porcine
eyes before and after the mounting procedure using OCT.
ACD before mounting [mm] ACD after mounting [mm]
2.23 2.27
1.63 1.11
1.78 2.06
1.44 1.84
2.06 1.63
1.99 2.08
1.71 1.96
1.57 1.82
FIGURE 5.7: Exemplary image of the SD-OCT setup to image porcine
eyes.
There was no significant (p>0.05) difference in corneal thickness (by 0.03 s´ 0.04 mm; p
= 0.163) and anterior chamber depth (by 0.18 s´ 0.33 mm; p= 0.100) calculated before
and after the mounting procedure, confirming that the porcine eyes could be dissected
andmountedwithout causing structural changes to the anterior segment morphology.
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TABLE 5.3: Central Corneal Thickness (CCT) measured in eight porcine
eyes before and after the mounting procedure using OCT.
CCT before mounting [mm] CCT after mounting [mm]
1.84 1.84
1.68 1.68
1.75 1.77
2.03 1.99
1.91 1.85
1.75 1.66
1.96 1.97
1.80 1.75
5.2.2 Environmental control system
The environmental control system was designed to recreate physiological IOP and
flow rate in the endothelial compartment, while reproducing intermittent irrigation
and air exposure to the porcine epithelium.
Endothelial perfusion
The endothelial perfusion system consisted of a microfluidic 4-channel, 12-roller, vari-
able speed peristaltic pump (ISM597, Ismatec REGLO, Wertheim, Germany) passing
temperature controlled physiological solution (Dulbeccos Modified Eagles Medium
(DMEM; Lonza, Berkshire, UK), supplemented with 1% penicillin (10,000 units/ml)
and streptomycin (10,000 mg/ml), 1% v/v L-glutamine (Lonza, Berkshire, UK), 10%
Foetal Bovine Serum (FBS; Sigma-Aldrich, UK)) through the perfusion chamber at a
monitored intraocular pressure (IOP). The temperature of the biological solution was
set at 37◦C and controlled using a digital, PID controlled hot plate (SH-5H, MESE Ltd.,
Leeds, UK), while the IOP was controlled via compensated gauge pressure sensors
(ADP51B63, Panasonic, Bracknell UK) and adjusted by altering the height differential
of the solution to create a pressure in the anterior chamber 18-20 mmHg higher that
atmospheric pressure. Flow rate was set to 1 ml/min to ensure constant delivery of
culture medium into the anterior segment maintaining constant perfusion pressure.
Main parameters of the endothelial perfusion system are reported in Table 5.4.
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TABLE 5.4: Main parameters of the endothelial perfusion system.
Parameter Setting
Medium temperature 37◦C
Flow rate 1 ml/min
IOP 18 20 mmHg
FIGURE 5.8: Experimental image of four porcine anterior segments
mounted in the Aston biological anterior eye model and perfused with
transparent DMEM at 37◦C at 1ml/min, under 18-20 mmHg.
Figure 5.8 illustrates four porcine anterior segments mounted in the Aston biological
anterior eye model and connected to the endothelial perfusion system, clearly show-
ing that the model was capable of maintain anterior chamber patency.
Epithelial irrigation
A human eye holds approximately 30 µL of tears, and spontaneous blinking helps to
spread the tear film evenly across the ocular surface (Gurung et al. 2016). Mimicking
tear replenishment in the eye requires the delivery of a tear analogue to the surface
of the ex-vivo eye model followed by a period of drying in a recurring fashion under
physiological conditions. Inspired by the tear replenishment spray system proposed
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by Mohammadi and colleagues in 2014, a novel tear replenishment engineering so-
lution was developed to recurrently spray tear analogue on the corneal epithelium,
sufficiently moisturising the surface of the model while maintaining the air-liquid in-
terface (Mohammadi et al. 2014).
The system was composed of a linear actuator activated by electronically controlled
relays. Once activated, the actuator pressed on the spray head mechanism of four 250
ml aluminium spray bottles, simultaneously moisturising four corneas with physio-
logical solution (Dulbeccos Modified Eagles Medium (DMEM; Lonza, Berkshire, UK),
supplemented with 1% penicillin (10,000 units/ml) and streptomycin (10,000 mg/ml),
1% v/v L-glutamine (Lonza, Berkshire, UK), 10% Foetal Bovine Serum (FBS; Sigma-
Aldrich, UK). Anterior segments secured in perfusion chambers were mounted verti-
cally to allow the excess fluid to automatically be drained, consequently avoiding the
need for aspiration systems and minimising costs (Figure 5.9).
FIGURE 5.9: 3D rendering of the automated spray system.
In detail, the linear actuator was driven by a 12V DCmotor requiring∼ 1 A of current
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(A)
(B)
FIGURE 5.10: DC Motor Direction control scheme using two SPDT re-
lays.
TABLE 5.5: 12V DC linear actuator specifications.
Specification Value
Load capacity 750 N
Protection class IP54
Input Voltage 12v DC
Speed 10 mm/s
Stroke Length 100 mm
to run (Table 5.5). Controlling the travel direction of the motor required reversing the
polarity of the electricity in input to the linear actuator. To achieve so, the motor was
wired in the configuration shown in Figure 5.10 to the power supply using an opto-
isolated relay board composed of 2 SPDR (Single Pole Double Throw) relays.
When both relays were off, both motor terminals were connected to the same point
and the motor was stopped. If one relay was activated, one motor terminal was con-
nected to the opposite polarity and the piston would run in one direction. If the other
relay was activated, the motor connected in the opposite polarity reversing piston di-
rection. Finally, if both relays were activated the motor would stop.
To automate the system, the relay board was governed by a microcontroller (Arduino
Mega, Arduino, Italy) coupled with a 4.3 colour TFT LCD Resistive Touch display (4D
Systems, Australia) programmed by the author to allow the user to visualise the IOP
of the connected chambers and to select the desired misting frequency (Figure 5.11).
Separate power sources for the motor and control were used due to the required cur-
rent for the linear actuator. In these regards, the relay board was opto-isolated to
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avoid any possible damage to the microcontroller due to back currents generated by
the heavy current load of the motor, and the touch display was chosen to be resistive
so to be easily activated when wearing laboratory gloves.
FIGURE 5.11: Electronic design scheme of the automated epithelial ir-
rigation system.
The electronics was enclosed in a custom-made 3D-printed box, and a PCB shield was
designed in KiCad (open source software suite for Electronic Design Automation) and
manufactured in China (Shenzhen JLC Electronics Co., Ltd.) to stabilise electronic con-
nections between the different electronic parts (Figure 5.12).
(A) (B)
FIGURE 5.12: Electronic enclosure rendering of the Aston Biological
Anterior Eye Model (A). Connecting shield PCB of the Aston Biological
Anterior Eye Model (B).
To avoid biological contamination, the whole system was fitted in a laminar flow cab-
inet (HeraGuard ECO, ThermoFisher, Germany), to protect the biological sample and
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avoid contamination. The final system, which is reported in the video footage no 2,
consisted of four test cells controlled by the same touch screen to allow incremental
differences to be examined simultaneously and to maximise experimental reliability
(Figure 5.13).
FIGURE 5.13: Experimental overview of the Aston Biological Anterior
Eye Model fitted in the laminar flow cabinet. Multichannel peristaltic
pump (1), PID controlled hot plate (2), porcine anterior chambers verti-
cally mounted (3), automated epithelial irrigation system (4) and asso-
ciated electronic box (4).
After the overall system was established, it was crucial to choose an appropriate ep-
ithelial irrigation frequency that could allow the external corneal surface to be hy-
drated in a physiological fashion. In humans, tear film stability is defined as the time
interval between a complete blink and the first occurrence of a dry spot in the tear
film (Lemp 1973, Norn 1969), and it is ideally clinically measured non-invasively us-
ing tear interferometry (Mengher et al. 1985, Wolffsohn et al. 2017). Therefore, the
epithelial hydration layer produced by the automated irrigation system was assessed
and optimised using a compact and portable tearscope (EASYTEARview+ All in One,
Easytear, Italy).
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Three porcine eyes were freshly enucleated at a local abattoir, and mounted in the As-
ton biological anterior eye model. After irrigation, changes in the reflection patterns
were video recorded and subsequently interpreted by the author and an optometrist.
Representative images are presented in Figure 5.14, which clearly shows that an irri-
gation frequency lower that 30s was required to ensure a stable epithelial hydration
layer on the porcine eye.
FIGURE 5.14: Representative NIBUT images on a porcine eye. The tear
film becomes unstable after 30s from irrigation.
Based on these findings, a 20s interval was selected as default irrigation rate in order
to replicate physiological tear dynamics, while still allowing for the 250ml aluminium
bottle refilling time to be ∼ 13hr, allowing experiments to be comfortably run over
night unsupervised.
5.3 Biological evaluation
Successful organ culture requires the long-term survival of cells, which can be evalu-
ated by estimating cell viability (CV), one of the most important parameters in tissue
engineering and culture studies (Johnson & Rabinovitch 2012). Staining and imaging
cells with vital fluorescent dyes is a highly versatile approach widely used among cell
biologists to estimate cell viability, as specific dyes are activated and retained only
in intact cells, providing positive markers for cell viability (Gantenbein-Ritter et al.
2008). To image 3D biological tissues, fluorescent dyes are imaged using multiphoton
confocal laser scanning microscopy (Figure 5.15), a technique which has the ability to
produce optical sections through a 3D sample by moving the focal plane through the
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depth of the biological specimen (Fischer et al. 2011).
FIGURE 5.15: 3D-stack image of a porcine cornea at stromal level. Be-
cause optical sectioning with confocal imaging is non-invasive, the 3D
distribution and relative spatial relationship of stained living cells can
be observed with reasonable clarity.
These techniques were hence adopted in this work to analyse the Aston biological
anterior eye model at cellular level and assess its viable time frame. Moreover, a clini-
cally relevant technique such as ’Conjunctival impression cytology’ (CIC) was applied
to test the feasibility of replicating in the model pathologies such as Dry Eye Disease.
5.3.1 Long term survival
Calcein AMwith EthidiumHomodimer-1 staining, commercialised as Live/Dead (In-
vitrogen, UK) Viability/Cytotoxicity Assay Kit provides a two-colour fluorescence cell
viability assay that is based on the simultaneous determination of live and dead cells
with two probes that measure intracellular esterase activity and plasma membrane
integrity. In particular, live cells are distinguished by the presence of ubiquitous in-
tracellular esterase activity, determined by the enzymatic conversion of the virtually
non-fluorescent cell-permeant Calcein AM to the intensely fluorescent calcein. The
polyanionic dye calcein is well retained within live cells, producing an intense uni-
form green fluorescence in viable cells (Table 5.6). On the other hand, EthD-1 enters
cells with damagedmembranes and undergoes a 40-fold enhancement of fluorescence
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TABLE 5.6: Excitation and Emission peaks of Calcein AM and Ethidium
Homodimer-1.
Fluorescent Dye Excitation peak Emission peak
Calcein AM 495 nm 515 nm
Ethidium Homodimer-1 495 nm 635 nm
upon binding to nucleic acids, thereby producing a bright red fluorescence in dead
cells (Figure 5.16). EthD-1 is excluded by the intact plasma membrane of live cells,
and background fluorescence levels are inherently low with this assay technique be-
cause the dyes are virtually non-fluorescent before interacting with cells.
FIGURE 5.16: Excitation (- -) and Emission (-) spectra of Calcein AM
(Blue) and Ethidium Homodimer-1 (Orange). The kit has been opti-
mised so to be able to excite both dyes with a single 488 nm multipho-
ton laser line, while still being able to independently capture emitted
signals on two different channels.
The viability of stromal fibroblasts was therefore visualised in six freshly enucleated
porcine eyes using the Live/Dead viability kit. Following the manufacturers protocol,
three porcine corneas were dissected and incubated with the recommended concen-
trations of calcein AM and ethidium homodimer (EthD-1) for 1 hour in the dark at
day zero. The remaining corneas were firstly cultured in the Aston biological anterior
eye model for seven days, and then dissected and stained as previously described.
Post-incubation, tissues were carefully washed with PBS and finally imaged on a mul-
tiphoton confocal laser scanning microscope (Leica, UK).
Live/Dead assay results are indicated in Figure 5.17, which clearly illustrates that
porcine stromal fibroblasts remained viable after seven days of organ culture in the
Aston biological anterior eye model.
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(A) (B)
FIGURE 5.17: Live/Dead images of a porcine cornea at day 0 (A) and
day 7 (B). Images have been chosen as a representative of three repli-
cates.
A representative image at higher magnification is reported in Figure 5.18, lucidly
showing the fibroblastic morphology of the analysed cell, confirming the correct vi-
sualisation of the corneal stroma.
FIGURE 5.18: Higher magnification representative image of corneal fi-
broblasts obtained using confocal microscopy.
Finally, a porcine anterior segment after seven days of culture is shown in Figure 5.19,
which indicates that the culture system did not cause loss of transparency in the
corneal and crystalline lens tissue, being able to preserve the crystalline lens in loco
throughout the whole culture period.
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(A) (B)
FIGURE 5.19: Transparent cornea (A) and crystalline lens (B) after 7
days of storage in the Aston biological anterior eye model.
5.3.2 Dry eye replication
Dry eye disease (DED) is generally defined as a disorder of the tear film caused by tear
deficiency or excessive tear evaporation (Craig et al. 2017). In this disease, the con-
junctival epithelium often undergoes a pathological transition to a keratinized non-
secretory corneal and conjunctival surface, characterised by epithelial cells squamous
metaplasia and goblet cell depletion (Murube & Rivas 2003). Conjunctival impression
cytology (CIC) represents a minimally invasive method to collect superficial epithe-
lium layers for analysing these changes at a molecular level via the application of
cellulose acetate filters over the ocular surface (Tole et al. 2001). As a result, CIC is
considered a clinically useful test in the diagnosis of DED, as it has shown a promis-
ing correlation with the duration of computer use (Bhargava et al. 2014), and it has
been used to evaluate the efficacy of topical cyclosporine in different grades of DED
(Yuksel et al. 2010). However, CIC studies on ex-vivo eye models are still not present in
the academic literature, leaving an open question about the possible use of this tech-
nique as a non-destructive monitoring method of the ocular surface in ex-vivo organ
cultures.Therefore, a feasibility study was conducted to explore the ex-vivo charac-
terisation of the porcine conjunctival surface using CIC, and the potential application
of this technique to assess the viability of replicating DED using the Aston biological
anterior eye model.
Nine freshly enucleated porcine eyes underwent conjunctival impression cytology
(CIC). Specimenswere respectively collected in three eyes immediately after themount-
ing procedure, three eyes after 2hr of culture in the Aston biological anterior eyemodel
with an irrigation rate of 20s, and three eyes after 2hr of culture in the Aston biological
anterior eyemodel with an irrigation rate of 40s (Evaporative Dry Eye condition). Two
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2x3 mm rectangular pieces of nitrocellulose filter paper (Pall, New York, NY, USA)
were cut and placed separately on the nasal and temporal bulbar conjunctiva with
filter paper dull-side down and held in place for 10 seconds under constant pressure.
The filter paper was then gently lifted and fixed with 96% alcohol. Haematoxylin and
periodic acid-Schiff (PAS) reagents were used to stain the cells. In particular, after a
minimum of ten minutes in 96% ethanol, the filter material was hydrated with dis-
tilled water (10 min), oxidised in 1% periodic acid (10 min), rinsed in distilled water
(3 min), and stained with Schiff’s reagent (3 min) (Li et al. 2012). Strips that developed
a pink colour were then rinsed in distilled water to provide oxidation (five minutes)
for following staining. Filter materials were counterstained with haematoxylin (20 s),
rinsed in distilled water (3 min), dehydrated by two successive baths of 96% ethanol
(2 minute each), two successive baths of 100% ethanol (2 minute each) and a bath in
xylene (9 min). Afterward, specimens were placed on a glass slide and permanently
mounted on a glass slide using Entellan (Merck KGaA, Darmstad, Germany), a rapid
mounting medium for microscopy (Figure 5.20).
FIGURE 5.20: Examples of CIC filter papers stained and permanently
fixed.
After staining, three different sections of each specimen were selected randomly for
evaluation under a light microscope with a 10X and 40X objective, and digital images
of representative areas were taken using a scientific CCD camera (Retiga R1, QImag-
ing, USA) camera and evaluated using the Nelson system (Nelson et al. 1983). This
grading system considers the density, morphology, cytoplasmic staining affinity and
nucleus/cytoplasm ratio of conjunctival epithelial and goblet cells to grade the ocular
surface in 4 stages (0-1: normal, 2-3: altered).
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Representative images are reported in Figure 5.21, which successfully shows epithelial
and goblet cell morphologic features on cytological impressions obtained from ex-vivo
porcine eyes, as well reveals cytological changes associated with the longer epithelial
irrigation frequency of 40s (Evaporative Dry Eye condition).
(A) (B)
(C)
FIGURE 5.21: Ocular surface samples before the mounting procedure
(A), after two hours of irrigation every 20s (B) and 40s (C).
At time zero, epithelial cells were healthy, small, and characterised by large, basophilic
nuclei with nucleocytoplasmic ratio of 1:2. Goblet cells were present, however not
oval (Figure 5.21, A). This abnormal feature may be an artefact due to the excessive
pressure of the filter paper on the porcine ocular surface, underlining the critical im-
portance of trained personnel for sample taking and processing.
An epithelial irrigation rate of 20s ensured the maintenance of a healthy conjunctival
epithelium. Epithelial cells remained small, and with a maximum nucleocytoplasmic
ratio of 1:3 (Figure 5.21, B). This is perfectly in line with our previous interferometric
findings, as an epithelial irrigation rate smaller than 30s was shown to ensure a stable
epithelial hydration layer on the porcine eye.
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Finally, an epithelial irrigation rate of 40s caused characteristic metaplastic changes
typical of Dry Eye Disease (Zuazo et al. 2014) just after 2 hours of culture. Epithelial
cells were hence large and polygonal, with small, pyknotic, and, in some cells, com-
pletely absent nuclei. Nucleocytoplasmic ratio was greater than 1:3, and goblet cells
were completely absent (Figure 5.21, C).
5.4 Discussion
Over the years, a great amount of research has been dedicated to the development
of laboratory alternatives that could minimise the use of animals wherever possible
(Kirk 2018). Alternatives to animal studies span from the complete to the partial re-
placement of live animals in biomedical research; in the ophthalmic field important
contributions have been made by the development of ex-vivo ocular models (Shafaie
et al. 2016). For example, in the early 1990s the Bovine Corneal Opacity and Perme-
ability (BCOP) and the Isolated Chicken Eye (ICE) ex-vivo ocular safety methods were
successfully validated by the regulators, and led to an estimated reduction in the use
of live animals for eye safety testing of more than 10% (Hood 2008).
For anterior eye investigations, although several ex-vivomodels have been developed
for the corneal and crystalline lens tissue (Chapter 2), any of them allows scientists
and regulators to retain the intercellular connections and interplays between these
two systems. This chapter described the development of a novel and complete ex-
vivo anterior eye model capable of sustaining the porcine cornea and crystalline lens
in a physiologically stable state in loco for up to seven days. The model has been
named the Aston Biological Anterior Eye Model, and its development encompassed
approximately 8,000 man hours of work across multiple engineering and biomedical
disciplines.
First of all, this platformwas based on porcine eyes, which are readily available slaugh-
terhouse waste and show the closest anatomical and biochemical makeup to human
eyes (Menduni et al. 2018, Groenen et al. 2012). This choice minimised not only the
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model developmental time and cost due to the inexpensive and high-quality nature of
the porcine tissue, but also the experimental effort that would be needed to adapt the
model to accommodate human anterior segments.
Secondly, the Aston biological anterior eye model overcame several of the challenges
and limitations of previously published instruments by culturing both the corneal and
crystalline lens tissue in loco for up to seven days. To achieve this, a bespoke ante-
rior segment dissection and mounting procedure was designed and optimised until
the biological specimen could be successfully clamped in the model within minutes.
Moreover, to ensure biological viability, an environmental control systemwhich main-
tained both tissues at physiologically realistic temperatures and hydration levels was
developed and tested. In particular, a peristaltic pump was coupled with a PID con-
trolled hot plate to perfuse temperature-controlled physiological solution through the
anterior chamber at a pressure monitored by a sensor, which could easily be adjusted
by altering the height differential of the solution. Additionally, the action of the tear
film was mimicked by creating a novel tear replenishment engineering solution recur-
rently spraying tear analogue on the corneal epithelium, sufficiently moistening the
surface of the model while maintaining the air-liquid interface. The whole system con-
sisted of four test cells controlled by the same touch screen to maximise experimental
reliability, and it was designed to be fitted in a laminar flow cabinet to avoid biologi-
cal contamination. Therefore, the model enabled porcine anterior segment storage in
sterile conditions, enabling optical measurements such as OCT and transparency as-
sessment to be performed in situ, and cellular samples to be easily collected at various
points in the model for biological analysis.
Further, cell viability was evaluated in the Aston biological anterior eye model using
confocal microscopy and conjunctival impression cytology (CIC). Stromal fibroblasts
were found to be viable after seven days of culturing, and conjunctival epithelial cells
did not show any sign of metaplasia when epithelial irrigation was performed every
20s, i.e. when a stable tear layer was maintained in the model. These initial find-
ing show the potential of the Aston biological anterior eye model to maintain porcine
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anterior eye tissue physiologically viable for a week, and represent a promising foun-
dation for further experimentation aimed at the full histochemical validation of the
model. The high number of biological techniques required to accomplish this goal
actually made it not achievable by the author within the PhD timeframe. However,
fruitful academic collaboration within Aston University and with other universities
have been established to reach this ambitious biological objective in the near future.
Finally, a study to assess the possibility of reproducing the damage to the ocular sur-
face caused by DED in the Aston biological anterior eye model was also carried out in
this chapter. Irrigating the corneal epithelium every 40s destabilised the artificial tear
layer, causing ocular surface desiccation and epithelial cells apoptosis. Effectively,
conjunctival epithelial cells showed metaplastic changes typical of DED after 2hr of
culturing, and conjunctival goblet cells were absent. To reinforce this findings, future
studies will be carried out to test the potential of simulating different severities of
DED, and to include in the Aston biological anterior eye model an immune system,
potentially upgrading this platform to the only tool available worldwide for studying
the multifactorial pathogenesis of this disease ex-vivo (Bron et al. 2017).
In conclusion, the Aston biological anterior eye model was able to preserve porcine
anterior segments for one week in a near natural physiological environment. If suc-
cessfully brought to market, this novel ex-vivo anterior eye model may play a key role
in the applied ophthalmic research, potentially bridging the gap currently existing
between in-vitro and in-vivo anterior eye investigations. As a result, the efficiency of
clinical trials may dramatically increase, ultimately allowing governments to better
redistribute healthcare funding.
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A Novel Training Platform for Ocular
Surgery
6.1 Introduction
In an era characterised by unprecedented ageing populations and decreased birth
rates, societies around theworld are constantly facing increasing healthcare challenges
to find sustainable ways to manage the complexity of this growing population with
pragmatism and respect for the patient (Nicol 2017). According to the last assessment
of The World Health Organization, 20 million people worldwide are blinded due to
age-related cataract formation, which remains the leading cause of avoidable blind-
ness in poor and emerging countries (Ellwein & Kupfer 1995). The goal of the Vision
2020: The Right to Sight initiative is to make high quality eye care services accessible
to all, and the treatment of cataracts has been identified as a major priority to eliminate
avoidable blindness by the year 2020 (Rao et al. 2011). Modern cataract surgery is a
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cost-effective intervention that restores vision. However, to achieve population wide
high quality eye health, it is essential to develop adequate and appropriate resources
that could enable the delivery of high quality cataract surgery with good visual out-
comes and patient satisfaction (Qureshi & Khan 2014).
According to consultant ophthalmic surgeons, supervised training and practice are
the cornerstones to reaching a level of expertise and experience that leads to good out-
comes in cataract surgery (Benjamin 2002, Coroneo 1990). Traditionally, ophthalmic
surgical training programmes were based on the Halsted apprenticeship model, in
which trainees performed surgical techniques step by step on actual patients under
close physician supervision (Grillo 2004). This model was characterised by high costs
of training during live surgery, and, most importantly, patient safety was often com-
promised. For these reasons, ophthalmic surgical training programmes have been
evolved during the last two decades, shifting towards a competency-based system
that could ensure that only surgeons who meet the defined benchmark progress even-
tually will operate on living patients (M et al. 2018). Posterior capsular rupture (PCR)
with or without vitreous loss is the most common intra-operative complication during
cataract surgery, and is widely agreed as the key indicator to judge surgical quality. In
the United Kingdom, there has been a trend for improvement from the mean bench-
mark rate of 4.4% in 1999 (Desai et al. 1999), to 2.68% in 2004 and 1.92% in a more
recent survey of 55 567 cases (Johnston et al. 2010). However, when analysing inter-
surgeon variation of this benchmark complication, PCR is found to be much lower for
independent surgeons (consultants, staff grades, and associate specialists,) than for se-
nior trainees and themost junior trainee surgeons (Figure 6.1). Therefore, a substantial
ethical concern regarding trainees operating on living patients still exists, especially as
at the onset of training the vast majority of first-year trainees have never performed
in vivo intraocular surgery, for which the learning curve remains very steep (Oetting
et al. 2006).
Time spent in practising surgical techniques in training laboratories (Wet labs) or in
simulated physical environment has been shown to be an effectivemethod to speed up
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FIGURE 6.1: Percentage of cataract operations complicated by PCR for
Indipendent Surgeons (I.S.), Junior Trainees (J.T.) and Senior Trainees
(S.T.).
the learning curve and reduce potential risks for the patients used as subjects for train-
ing (Velmahos et al. 2004). Ophthalmic surgical simulator, such as Eyesi (VRmagic
Holding AG, Mannheim, Germany), MicroVisTouch (ImmersiveTouch, Chicago, IL),
or PhacoVision (Melerit Medical, Linkoping,Sweden) use virtual reality technology to
simulate intraocular surgery (M et al. 2018, Alwadani 2018). However, the system’s
cost (between $100,000 and $200,000) still represents a barrier to the broad adoption
of this technology. On the other side, hands-on experience in surgical wet labs re-
mains the gold standard for surgical training as wet labs provide a risk-free environ-
ment where trainees can be introduced to the technical aspects of cataract surgery, and
trainers can develop professional teaching and communication skills. Handing over
individual technical steps of surgery to a trainee in wet labs allows the trainer to min-
imise operative time in the surgical theatres, and risk to the patient.
Along the years, human cadaver, porcine, or manufactured eyes have been used as
ex-vivo models for cataract surgery (Henderson et al. 2009). Although they allow for
inexpensive practice of intraocular surgery in a fairly reproducible manner, they have
been designed for mainly teaching basic steps in phacoemulsification or corneal su-
turing (Machuk et al. 2016, Sugiura et al. 1999). However, there are many challenging
scenarios or surgical complications that junior surgeon are likely to never encounter
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TABLE 6.1: Challenging scenarios for cataract surgery and their preva-
lence estimated from scientific literature.
Challanging scenario Estimated prevalence
Corneal opacification (Ho et al. 2018) 11.9%
Intraoperative floppy iris syndrome (IFIS) (Zaman et al. 2012) 2.33%
Small pupil (Halkiadakis et al. 2017) 1.6%
Zonular dialysis (Narendran et al. 2009) 0.46%
Paediatric cataract (Sheeladevi et al. 2016) 22.9/10000
during their training due to their low prevalence (Table 6.1). Practicing those compli-
cations in a wet lab environment would further reduce patient risk and, at the same
time, highly increase the robustness of wet lab cataract models.
The Aston biological eye model described in the previous chapter is the only ex-vivo
anterior eye model capable of maintaining both the porcine corneal and crystalline
lens physiologically stable in loco for several days. This unique feature may allow
this model to be also used as a training tool suitable for mimicking different cataract
surgery scenarios, and this chapter evaluates the further engineering of this model to
assess the feasibility of this assumption.
6.2 Methods
6.2.1 Wet Lab for animal tissue handling setup
A viable wet lab for animal tissue handling was established within Aston Univer-
sity (Figure 6.2). It consisted of an ophthalmic surgical microscope (Zeiss, Germany)
coupled with a Nikon D5200 digital camera, a phacoemulsification machine (Zeiss,
Germany), a working surface for sample handling, a sink with water supply, a storage
space and a refrigeratorfreezer.
Standard Operating Procedures (SOPs) were defined and risk and chemical assess-
ments were carried out before any work with biological samples and chemicals com-
menced to mitigate any potential hazards (see Appendix A). In particular, personal
protective items to bewornwere defined, hazardous chemicals to be stored in flammable
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(A) (B)
FIGURE 6.2: Exemplary pictures of the working area for ophthalmic
surgery training in the Aston wet lab.
storage cabinets were identified and sterilisation and disposal procedures for the bio-
logical and non-biological waste were described.
6.2.2 Perfusion chamber re-engineering
The Aston biological eye model needed to be re-engineered to ensure feasibility of
the cataract surgery procedure using the model. First of all, due to the great amount
of stress and pressure created by the phacoemulsification, the porcine anterior seg-
ment had to be extremely secured to the perfusion chamber. To do so, the ante-
rior segment was fixed to the chamber by gluing the scleral rim to the PTFE using
3MTM VetbondTM, a veterinary approved tissue adhesive (Figure 6.3). This 2-octyl
cyanoacrylate adhesive polymerises in seconds without creating an exothermic reac-
tion and releasing irritant cyanoacetate and formaldehyde, and contains a blue dye
for easy-to-see drop application (Jenkins & Davis 2018). Using the tissue adhesive
allowed to extremely secure the porcine tissue to the chamber throughout the whole
surgical procedure, avoiding any fluid or pressure loss.
Secondly, the frontal aperture of the perfusion chamber that exposes the porcine tis-
sue to the surgeon required design modification to fully accommodate the optimal
positional of surgical instruments during cataract. In particular, during the surgical
procedure the trainee needed to access the limbus from the side to create a pars-plana
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(A) (B)
FIGURE 6.3: 3MTM VetbondTM tissue adhesive (A); porcine anterior
segment glued to the perfusion chamber (B).
clear incision into the porcine cornea. Unfortunately, the original design of the cham-
ber did not allow sufficient tissue exposure, resulting in an angled incision architecture
of 22.5◦ (Figure 6.5).
(A)
(B)
FIGURE 6.4: A non-horizontal corneal incision using the original per-
fusion chamber. The surgeon did not have enough space to access the
cornea as in a real-life cataract. The angle of the corneal incision was
evaluated using ImageJ software.
After evaluating the 3D CAD designs of the perfusion chamber, the optimal engineer-
ing compromise between manufacturing time and model adaptation was found into
grooving a slot in the perfusion chamber with a width of 30 mm and a depth of 5mm.
These dimensions allowed the tissue to be completely exposed to the surgeon, while
still offering enough mechanical structure for tissue anchoring.
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(A) (B)
FIGURE 6.5: A non-horizontal corneal incision using the original per-
fusion chamber. The surgeon did not have enough space to access the
cornea as in a real-life cataract. The angle of the corneal incision was
evaluated using ImageJ software.
The modified aperture more closely mimicked the ordinary operating field of view,
allowing the surgeon to successfully create a pars-plana corneal incision at the limbus
with an angle smaller than 10◦.
FIGURE 6.6: Horizontal corneal incision using modified perfusion
chamber. The surgeon had enough space to access the cornea as in a
real-life cataract. The angle of the corneal incision was evaluated using
ImageJ software.
6.2.3 Cataract surgery
Five porcine eyes were freshly enucleated at a local abattoir before scalding and trans-
ferred to the laboratory in a transport solution at 4◦C. The transport solution con-
sisted of Dulbeccos Modified Eagles Medium (DMEM; Lonza, Berkshire, UK), sup-
plemented with 1% penicillin (10,000 units/ml) and streptomycin (10,000 mg/ml),
1% v/v L-glutamine (Lonza, Berkshire, UK), 10% Foetal Bovine Serum (FBS; Sigma-
Aldrich, UK) and 20% w/v Dextran (Mw ∼ 250kDa, Sigma-Aldrich, UK) to minimise
corneal swelling. Animals were white domestic pigs aged between 12 to 25 weeks. To
avoid tissue deterioration, eyeballs were dissected and mounted in the devised cham-
bers on arrival to the laboratory, and cataract surgery was performed on the same day.
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Six millimiter optic foldable acrylic and silicone intraocular lenses (IOLs), lens injec-
tors, 1.4% high molecular weight hyaluronic acid (HA) and ophthalmic viscosurgical
devices (OVD) were obtained by Rayner Ltd., the company that manufactured the
worlds first IOL and the only manufacturer of IOLs in United Kingdom (Worthing,
BN15 8AQ). A trainee with a log of over one hundred cataract cases was enrolled
for performing the surgical procedures, and was supplied with surgical instruments,
blades, irrigating solution, and irrigation/aspiration tips needed to perform the sur-
gical procedure (Figure 6.7).
FIGURE 6.7: Trainee preparing a porcine eye for cataract surgery.
6.2.4 Inducing cataract in porcine eyes
Although pig eyes resemble humanmorphology, pigs anterior capsule is thicker, more
viscous and more elastic (Sanchez et al. 2011). As a consequence, the feel of perform-
ing continuous curvilinear capsulorhexis (CCC) differs from that in human eyes and
practicing nucleofractis techniques such as divide and conquer and phaco chop may
be difficult (see Appendix B). To overcome this limitation, the possibility to induce
cataract in porcine lenses to simulate human cataract was investigated in this chapter.
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In the literature, the most promising way to achieve this appears to be the combina-
tion of a microwave heating for at least 5 seconds and an injection of a formaldehy-
demethanol mixture (formaldehyde 38% andmethanol 100%, 2:1 ratio) left for 15 min-
utes before irrigation under viscoelastic endothelial protection (Saraiva & Casanova
2003, Shentu et al. 2009). This technique was tested in three porcine eyes freshly enu-
cleated before scalding. Globes were placed with the cornea facing upwards in the
centre of a small microwave-compatible container, and microwave heated for time in-
tervals ranging from 5s to 10s with a set power of 700 mW. Subsequently, a 15-minute
chemical injection of formaldehydemethanol mixture was performed by the trainee in
each eye.
6.3 Surgical Results
6.3.1 Non cataractous eyes
Four sutureless cataract surgery procedureswere successfully performed by the trainee,
followed by IOL implantation. Every step of surgical procedure was distinctly per-
formed, as clearly shown by the video footages 3-6 that have been supplied as sup-
plementary data. In particular, after having stabilised the porcine anterior segment in
the perfusion chamber, the surgical procedure started with a clear corneal incision ob-
tained using a trapezoidal blade precisely matched in width to the phaco tip to avoid
conjunctival chemosis (Figure 6.8).
FIGURE 6.8: Cataract surgery on a porcine eye: sutureless clear corneal
incision.
To ensure optimal flattening of the anterior lens capsule and to maintain anterior
chamber shape, the anterior chamber is filled with OVD (Figure 6.9).
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FIGURE 6.9: Cataract surgery on a porcine eye: anterior chamber filling
with OVD.
Once the anterior chamber is filled with OVD, the capsule is punctured centrally with
a sharp bent cystotome needle or a sharp capsule forceps and the tear is guided away
from the centre to easily grasp the developing flap with the forceps (Figure 6.10).
FIGURE 6.10: Cataract surgery on a porcine eye: anterior capsule tear-
ing for continuous curvilinear capsulorrhexis (CCC).
The tear is then continued in a circumferential direction to create a flap edge. Once
the flap is elevated, continuous curvilinear capsulorrhexis (CCC) is performed. The
optimal diameter of the capsular opening is currently believed to be about 5 mm in
uncomplicated procedures. This allows the CCC rim to cover the edge of the 6-mm
IOL optic (Figure 6.11).
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FIGURE 6.11: Cataract surgery on a porcine eye: capsular opening ob-
tained by continuous curvilinear capsulorrhexis (CCC).
After continuous curvilinear capsulorrhexis, the anterior capsule is elevated and hy-
drodissection and hydrodelineation of the nucleus is performed to free the nucleus
from its cortical attachments for disassembly and removal (Figure 6.12).
FIGURE 6.12: Cataract surgery on a porcine eye: hydrodissection and
hydrodelineation of the nucleous.
Subsequently, the phaco tip of the right size is inserted and using moderate flow, low
phaco power, and low vacuum, the nucleus is fractured. Due to the high elasticity of
the porcine capsule and the softer nucleus of the essentially healthy porcine sample,
sculpting and fracturing techniques could not be practiced as the lens was always as-
pired as a whole (Figure 6.13).
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(A) (B)
FIGURE 6.13: Cataract surgery on a porcine eye: phacoemulsification
of the nucleous.
Once the nucleus and soft cortical lens matter were removed, the lens capsule bag is
filled with OVD. The trainee loaded the IOL in the injector which was inserted into
the eye, bevel down. The IOL was gently injected with the leading haptic pointing
to the left in its proper orientation. Before the optic exited the cartridge, the leading
haptic and lens optic were placed in the lens capsule bag before complete unfolding
(Figure 6.14).
FIGURE 6.14: Cataract surgery on a porcine eye: : IOL insertion in the
capsular bag.
The trailing haptic was then positioned into the bag and the optic centred. Residual
OVD was removed utilizing the irrigation/aspiration hand-piece with low aspiration
settings (Figure 6.15).
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FIGURE 6.15: Cataract surgery on a porcine eye: remaining OVD is
removed with the lens remaining well centred.
6.3.2 Cataractous eye
Microwave heating produced a significant posterior cataract to an extent proportional
to the heating time. A minimum period of 7 seconds was required to create a homo-
geneous opalescent cataract in the porcine lens, however corneal clarity drastically
decreased with heating (Figure 6.16).
(A) (B)
(C) (D)
(E) (F)
FIGURE 6.16: Cataract induction in porcine globes by microwave heat-
ing for 5s (A-B), 7s (C-D) and 10s (E-F).
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The chemical injection did not produce any opacity improvement in the short period,
and after 24hr corneal haze became excessive, causing globe to be un-suitable for op-
eration (Figure 16).
FIGURE 6.17: Porcine globe 24hr after microwave heating for 7 seconds
and 15-minute chemical injection of formaldehydemethanol mixture.
A sutureless cataract surgery procedure was performed by the trainee on a cataractous
porcine eye, which is reported in the video footage no 7 supplied as supplementary
data.
6.3.3 Trainee feedback
Scores from the trainee feedbacks are summarised in (Table 6.2).
TABLE 6.2: Summary of the trainee’s feedbacks on the cataract surgery
performed on the Aston Biological Anterior Eye model.
Surgical step Non cataractous model Cataractous model
Cornea 4 2
Incision 4 4
Iris 2 2
Lens capsule 2 4
CCC 4 4
Hydro Dissection 3 2
Phacoemulsification 3 2
Soft Lens Matter Removal 1 1
Intra ocular lens insertion 5 4
Total 28 25
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The trainee was highly satisfied by both the non cataractous model and the level of
cataract induced. However, the corneal opacity generated by the microwaving treat-
ment significantly reduced intraocular visibility, resulting in an overall poorer surgical
model than intact porcine eyes (see Appendix C).
6.4 Discussion
During World War II, Sir Harold Ridley, an English ophthalmologist, devised the first
IOL out of Perspex after observing that splinters of acrylic plastic from aircraft cockpit
canopies did not trigger inflammation in Royal Air Force pilots injured eyes, provided
they did not touch the iris. On 29 November 1949 at St Thomas’ Hospital, Ridley
achieved the first implant of an IOL, although it was not until 8 February 1950 that he
left an IOL permanently in place in an eye (Jaffe, 1996). Since then, cataract surgery
has developed vastly, becoming the most prevalent operation worldwide, with more
than 15 million artificial IOLs implantations performed every year (Rush et al., 2015).
The delicate nature of ocular tissues and narrow margin of error necessitates surgical
precision. Competent surgical performance requires hands-on-training of key surgi-
cal steps to such an extent that the American Board of Ophthalmology recommended
adding surgery as a core competency required to obtain accreditation in ophthalmol-
ogy (Mills and Mannis, 2004). In this regards, wet labs represent safe harbours where
trainees can be introduced to the technical aspects of the surgery, and develop surgical
confidence and adaptability that allows their time spent in the operating theatre to be
more productive and safer (Henderson et al., 2009).
Typically, wet labs use human cadaver, porcine or manufactured eyes as a surrogate
for human tissue, but none are perfect in simulating actual surgery (Machuk et al.,
2016). A successful wet lab model for cataract surgery should provide realistic vi-
suospatial and tactile feedbacks to acquire precise psychomotor skills and develop
micro-surgical spatial awareness that can be applied to real-life cataract surgery. In ad-
dition, it should be reliable, accurate, cost effective and easily reproducible (Kaplowitz
et al., 2018). This chapter investigated the use of the Aston biological anterior eye
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model as a reliable wet lab model for cataract surgery training, potentially overcom-
ing many of the drawbacks associated with previous wet labs eye models.
The Aston biological anterior eye model is based on porcine eyes, a readily available
source of inexpensive high quality tissue. Human cadaver eye with a clear cornea and
a well-developed cataract are extremely difficult to find, and artificial eyes manufac-
tured from various materials can only simulate some steps of the surgical procedure
(Sengupta et al. 2015). Here, four un-treated porcine eyes have been securely mounted
in the perfusion chambers and four IOLs have been successfully implanted in them.
The secure mounting procedure allowed the trainee to perform every step of the sur-
gical procedure without any tissue torsion or IOP loss, guaranteeing accurate tactile
feedback and stable intra-globe optics without the need of frequent injection of fluid
or OVD. In addition, the modified chamber with a greater frontal aperture was highly
rated by the trainee, as he could perform a clear horizontal entry in the cornea with a
keratome, previously difficult to achieve due to the relatively poorer exposure of the
tissue (see Appendix B).
Nonetheless, the essentially healthy pig lenses were not cataractous, but they were
very soft. On one side, this difference represents a model strength as enables the
porcine lens to better replicate pediatric capsulotomy, procedure that trainees rarely
encounter during their training period. In addition, as evident from the trainee feed-
back, this model smoothly resembles other unusual surgical scenarios such as small
pupil and IFIS (see Appendix B), further emphasising the great potential of this model
in reducing patient risk associated with surgical training (Messano et al. 2013). Per
contra, this appears to be a substantial model limitation as performing CCC and pha-
coemulsification is generally recognised by trainees as the most challenging step of the
cataract surgery procedure (Mohammadpour et al. 2012). For this reason, cataract was
attempted to be induced in porcine lenses to simulate human cataract. Microwave
heating at 700mW for a minimum of 7s produced a significant posterior cataract,
which appeared though not to be enhanced by a further injection of formaldehy-
demethanol mixture. This finding differs from previous scientific reports, however the
difference may be due the arduous learning curve required to properly treat eyes with
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chemical based treatments (Machuk et al. 2016). Inducing cataract should therefore
be a pre-requisite of a successful porcine anterior segment model for cataract surgery
training. Even if microwave heating the porcine globe for at least 7s represented a
basic and rapid method to prepare the crystalline lens with minimal effort, a stan-
dardised treating protocol is still needed to preserve acceptable corneal clarity and
minimise cellular damage.
Finally, it is crucial to consider that the Aston biological anterior eye model is a re-
search platform specifically developed for maintaining corneal and crystalline lens
tissue physiologically stable for a period of time of one week. This actually means
that the Aston model is the only platform currently available that enables tissue cul-
ture of pseudophakic eyes over several days, paving the way for the possibility of
practicing IOLs exchange, examining corneal and lenticular wound healing and fibro-
sis, studying posterior capsule opacification (PCO), IOLs orientation, and the effect
of different IOLs coating procedures ex-vivo Figure 6.18). Coupling those new clinical
outcomes with the motion analysis of the surgical video recordings will allow senior
educators to provide a clear set of goals to lab participants, creating an enhanced, re-
alistic educational experience.
FIGURE 6.18: Back-side view of an IOL implanted in the Aston Biolog-
ical Eye Model.
In conclusion, the Aston biological eye model represents a unique wet lab training
model for cataract surgery, characterised by high-fidelity guiding benchmarks for
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evaluating progression towards proficiency never achieved before. If successfully
brought to market, this wet lab model may have the potential to reshape the future
format of ophthalmic specialist training, bridging the gap between text-book surgery
and real-life theatre experience, and, ultimately, maximising patient safety in an era
where the cost of care is one of the strongest selective pressures driving practice pat-
terns.
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Lailah Gifty Akita
7
Conclusions
The work detailed in this thesis adds testament to the benefits of working at the in-
terface of biomedical engineering and optometry, by describing the development and
refinement of a laboratory platform "The Aston Biological Anterior Eye Model", which
aims to fill the existing gap between in-vitro and in-vivo anterior segment investiga-
tions in ophthalmology.
A novel and complete ex-vivo anterior eye model has been created, which is capable of
sustaining the cornea and crystalline lens in a physiologically stable state in loco for
up to 7 days. The platform is based on porcine eyes, which are not only the best high
quality and reliable human tissue source substitute, but as they are slaughterhouse
waste, also perfectly align the project with the 3Rs principles of replacing, refining and
reducing living animal experimentation (Kirk 2018). Furthermore, the model is mod-
ular and scalable, allowing for the maximisation of experimental reliability, and the
minimisation of waste and energy use. In addition, as the whole system is designed to
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be fitted in a laminar flow cabinet, it avoids external biological contamination, and is
easily transportable between tissue engineering laboratories, maximising accessibility.
As the first of its kind, this model may have effective applications in applied and pre-
clinical research in fields involving ocular surface tissue investigations, inclusive of,
but not limited to: ophthalmology, cosmetics, and pharmacological development and
testing. For example, the similarity in anterior corneal curvature between porcine and
human eyes, coupled with the novel tear replenishment solution engineered in this
study, may be useful in the study of new contact lens materials, helping them be op-
timised for physiological compatibility. The efficacy of new artificial drops could also
be evaluated using this model. In addition, epithelial irrigation can be easily manip-
ulated to simulate different severities of Dry Eye Disease (DED), potentially allowing
studies to elucidate the basic science behind its association with contact lens wear.
Moreover, owing to the unique in loco preservation of the corneal and crystalline lens
tissue, this model is the only platform currently available that could allow scientists
to systemically evaluate intraocular lenses (IOLs) implantation ex-vivo. By doing so,
the enormous cost and potential safety implications of clinical trials of new IOL de-
signs and materials, could potentially be reduced, along with associated regulatory
approvals relating to ophthalmic instrumentation. Additionally, as exacerbation of
ocular surface disease which may result in dry eye symptoms is a known potential
corollary of intraocular surgery and is generally recognised as a major reason for pa-
tient discomfort after cataract surgery, this model could become a powerful laboratory
platform to advance the understanding of its underlying mechanisms, which are cur-
rently unclear due to the complex and multifactorial pathophysiology of the disease.
Similarly, the model may have potential applications for enhancing methods of oph-
thalmic specialist training for intraocular surgery. Themounting of freshly enucleated,
un-scalded porcine eyes to the model was shown to provide a simple, cost-effective,
reliable and reproducible training platform, which offers clear corneas for the prac-
tice and perfection of new surgical techniques, in a risk-free environment, ultimately
increasing patient safety.
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A summary of the main findings of this thesis by chapter is detailed below:
Chapter 2 systematically reviewed existing ex-vivo ocular surface models, their appli-
cations, merits and limitations. This review highlighted that replication of physiologi-
cal anterior segment conditions ex-vivo strictly requires hemispherical dissection of the
globe, independent corneal endothelial and epithelial irrigationwith suitable media to
replicate tear film dynamics and to ensure endothelial cell viability, and high quality
relevant biological tissue. Porcine eyes were found to be the best human alternative
in terms of anatomical parameters and accessibility, however scarse information were
found in literature regarding the optimal enucleation and storage condition of the bi-
ological specimen.
Chapter 3 hence evaluated the optimal preservation technique for porcine eyes in re-
spect to corneal transparency and tissue deterioration combining invasive and non-
invasive characterisation techniques of biological tissue, highlighting that the success
and utility of experimental tests is highly dependent on the condition of the porcine
eyeball at enucleation. As such, corneal transparency and epithelial integrity were
identified as reliable indicators of eyeball condition. Un-scalded porcine eyes, stored
at 4◦ C in supplemented phenol red-free DMEM, and used within 36 hours of enucle-
ation were shown to guarantee optimum ocular tissue quality.
Chapter 4 therefore utilised this standard preservation protocol to reproducibly in-
vestigate the anatomical biometry of the porcine globe, via optical mapping, confocal
microscopy, ultrasonic pachymetry and optical coherence tomography (OCT). This
study is the biggest anatomical characterisation of the porcine eye which exists in the
scientific literature, and successfully shows that porcine corneal curvature is similar
to that of the human eye, highlighting the potential suitability of the porcine eye for
studies which assess contact lens fitting. Moreover, the biometric data obtained in this
study served as a reference for the mechanical design of the Aston Biological Anterior
Eye Model.
Chapter 5 described the engineered design of the "Aston Biological Anterior Eye Model"
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from its inception, refinement and subsequent testing and validation. To date, this
platform overcomes several of the challenges and limitations of previously published
models by uniquely maintaining the whole porcine anterior segment physiologically
stable for up to 7 days, consequently posing the base for further studies to expand
its applications. For example, a replication of the blinking mechanism could be de-
veloped to allow for frictional forces between the cornea and the bulbar conjunctiva
to be studied. This upgrade will pose a real engineering challenge as would require
fine control of shear stress between soft tissues. Biologically, immunohistology could
be performed to further validate the model on a cellular level. A similarly exciting
future avenue to explore would be the integration of an immune system within the
ex-vivo platform, to enable study of the prominent role of inflammation which is an
already recognised factor in the development and propagation of DED. A possible
way to achieve this would be the integration of Neutrophils (the most abundant type
of white blood cells in most mammals) in the perfusion media, to mimic neutrophil
migration into the corneal stroma following epithelial surface injury, a process which
is evident in-vivowithin a few hours of injury.
Chapter 6 finally explored the possibility of using the Aston Biological Anterior Eye
Model described in the previous chapter as a wet lab training tool for cataract surgery.
The model was successfully re-engineered to allow every step of the surgical proce-
dure to be performed without any tissue torsion or IOP loss, guaranteeing accurate
tactile feedback and stable intra-globe optics, and a significant posterior cataract was
successfully induced in the porcine lens via a microwave treatment at 700mW for a
minimum of 7s. Five cataract surgeries were successfully performed, and five IOLs
were successfully implanted ex-vivo.
In conclusion, advancing human health nowadays requires a multidisciplinary ap-
proach, which has been adopted in this thesis to answer the research questions posed
(Figure 7.1). Future aspirations of the project will focus on expanding the research
into an enterprise based business model, with funding from industry and government
sources, which could allow first-class scientists of different backgrounds to work to-
gether in devising the to-go-to platform for pre-clinical anterior segment investigation.
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FIGURE 7.1: Advancing bioengineering for the improvement of human
health and wellbeing requires multidisciplinary collaboration.
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~ 
Aston University 
Reference: 
RISK ASSESSMENT OF WORK WITH BIOLOGICAL MATERIALS 
This form is for work with Biological Materials. Risk assessment is mandatory under Health & safety 
regulations and Biological material comes under the COSHH regulations: 
http://www. hse. qov. uk/pubns/books/15. htm 
Astan University only has facilities for Category 2 Biological work. Work must be approved by the 
Biological safety Sub-Committee. 
This form is not for Genetically Modified work please complete a 
GM risk assessment for that work. 
1 Date submitted : 1 20.03.17 1 Date approved: 
Part A: Please provide the following general information: 
School/Department: Life and Health Sciences 
Principal Francesco Menduni Position : Phd Student 
E-mail address: f.menduni@aston.ac.uk Phone +447490733327 
Please give a brief and descriptive title far this risk assessment 
Title: Risk Assessment for ex-vivo porcine eye model 
Aims and objectives of investigation: 
The aim of the investigation is to develop a novel porcine anterior eye model that ~ould maintain 
both the corneal and the crystalline lens tissue physiologically stable for at least 10 days, to allow 
the rapid, but safe, development of innovative sight enhancing ophthalmic devices. 
Workers involved in work: Post/experience/training: 
Tugcelpek PhD Student working in the same European Dry Eye 
Network (EDEN). She is experienced in cell culture. 
Training and Assessment of Competence 
Specify arrangements for provision for existing and future personnel 
Training for COSHH assessments 
1 
~ 
Aston University 
Part B: Please indicate the type of Biological material that you will be using: 
Section 1: 
Section 2: 
Section 3: 
Section 4: 
Section 5: 
Micro-organisms (viruses, bacteria, fungí, parasites) 
ce// cultures 
human tissues and body fluids 
plants and plant material 
animals and animal tissues 
Section 1: Micro-organisms 
Nature of organism 
Reference: 
Name and Strain ACDP So urce Antibiotic Virulence properties 
cat.* susceptibility /resista nce 
Has any strain been genetically modified in any way? Yes/ No (Delete, as appropriate) 
* htt1;rLLwww.hse.gov.ukLQubnsLmisc208.Qdf 
lf yes, complete GM risk assessment form 
Quantity of organisms to be used 
volumes to be worked with concentrations of organisms to be used 
Section 2: Cell cultures 
Nature of cells 
Na me Anatomical and species origin 
Are the cells derived from a person who currently has access to the laboratory where the work will 
be performed? Yes/ No 
NB Persons MUST NOT work on their own cells 
lf yes, what precautions are to be taken to prevent that person being exposed to the cells? 
Have they been modified in any way (e.g., by transfection, transformation etc.)? Yes/ No 
lf yes, complete GM risk assessment form 
2 
~ 
Aston University 
Reference: 
Section 3. Human tissues and body fluids 
Nature of tissues and ~ody fluids 
Site of tissue, nature of body fluid(s): 
Details of human subjects from which tissue/body fluid is obtained (including likely presence of 
infective agents): 
Human Tissue Act: lf using Human Material you must use the Universities HTA Quality Manual and inform 
the HTA Designated Individual (DI) what you are using. 
The basis of compliance with the act in using Human material is informed consent and ethical approval. 
Section 4. Plants and plant tissue or material 
Nature of plant or plant tissue 
Name: 1 
Is it infected with a pathogen? Yes/ No (Delete as appropriate) 
lf yes, also complete section 1 
Is it transgenic? Yes/ No (Delete as appropriate) 
lf yes, complete GM risk assessment form 
Section S. Animals and animal tissues 
Nature of animal or tissue: 
Species Sex Anatomical site Origin or geographical 
source 
Po reine Fema le, E yes United Kingdom 
Mal e 
Is the animal or tissue/body fluid to be worked with infected orto be infected? Yes/ No 
lf Yes, also complete section 1 of this form 
Is a carcinogen, drug, or other substance to be administered to the animal(s) or present in the 
tissue? 
Yes/ No 
lf Yes complete appropriate Chemical COSHH assessment. 
Have the investigators that will be performing work on animals obtained the appropriate Home 
Office Licence? Yes/ No 
lf No consult the Manager of the Bio-Medical Unit. 
Have Standard Operating Procedures {SOPs) for the proposed work been sent to, and approved by, 
the Manager of the Biomedical Unit? Yes/ No 
lf No, send SOPs to the Manager of the Bio-Medical Unit. lf Yes attach signed approval 
3 
~ . 
Aston University 
Reference: 
Part C: Risk Assessment. Please provide the following information: 
Within this section inc/ude control measures put in place to mitigate any riskfrom the work, please 
attach any other relevant documentation e.g. Methods (Standard Operating Procedures}, other 
linked risk assessments. 
Risk to Humans 
Likelihood of hazardous risks to laboratory workers (including infection, allergy, toxicity etc.): 
Should pose no risk to health as long as good laboratory practice is observed. 
Humans at increased risk (e.g. Pregnancy, lmmunocompromised) 
lnterim Containment 
1 ACDP level: 
Are any of the work procedures likely to generate aerosols? lf so, should the work be 
undertaken in a safety cabinet? 
Does your laboratory avoid the use of sharps? 
Protective equipment and clothing to be used (state the type/grade or make to indicate 
control) 
Gloves (type 11), lab coats, safety cabinets (class 1 and class 11), safety googles, safety masks. 
Transport and storage arrangements: 
Are materials to be moved outside lab/suite? (e .g., between labs, between buildings, on public 
roads, posted) lndicate control measures, procedures and po/icies used. 
Porcine eyeballs will be transported from abattoir to campus in sealed plastic containers. 
On campus, eyes may be moved from Optegra Wetlab to Main Building in sealed plastic 
containers. 
4 
~ 
Aston University 
Reference: 
Disinfection 
Specify dilutions of disinfectants. Specify disinfection regime (What, Where When) . Have these 
disinfectants been validated far use with recipient micro-organisms, include reference if appf icable. 
Use of 70% Industrial Methylated Spirit (IMS) and 70% Ethanol for spraying surfaces to maintain 
aseptic technique. 
Sterilisation and Disposal procedures 
Autoclave will be used for material and solution required to be sterile. 
Sharp material will be collected in the sharps bin . Once full, the sharps bin is sealed shut and taken 
away for externa! incineration. 
All waste will be autoclaved before being taken away for incineration. 
Porcine eyeballs will be frozen down and collected in the freezer using plastic bags. Mr Wayne 
Fleary (Aston University) will collect them for final disposal. 
Environmental impact: 
Outline any impact that could occur if released into the environment and controls in place to mitigate any 
risk 
Environmental impact is less likely to happen in this study. 
Emergency procedures: 
To be followed in event of spills or accidental exposure to t issues or body fluids, e.g., needle stick accidents 
Splashes should be immediately cleaned with water. The incident should be reported to the 
manager. 
Occupational Health issues 
Any requirements for immunization, health monitoring etc. 
Additional containment 
e.g. Any special requirements for other legislation such as counter terrorism 
No. 
5 
~ . 
Aston University 
Reference: 
Part D: Authorisation and Notification: 
The work proposed can be discussed with the LHS School Technical Manager or the Schools 
Biological Safety Advisors or the University Biological Safety Officer far clarification etc. 
Consultation with other laboratory users should also take place. 
Completed assessments should be sent to the University Biological Safety Officer to be 
ratified by the University Biological Safety Sub-Committee. 
Signature of 
proposer 
Please print name 
Signature of 
Biological Safety 
Officer or authorised 
Deputy 
Please print name 
Signature of the 
Manager of the Bio-
Medical Unit (where 
appropriate) 
ti di 1 • 
· .. .. ~.  .. .. . N~ .......... . Date ...... 20.03 .17 .. .... .. .. .. 
Francesco Menduni 
Date 
Date 
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Aston University 
Binningham 
COSHH Summary - 2301 CA 
lnternal Reference: IMSCOSHH 
Assessed By PhD Student on 02 / 0312017 
lnfarmation vali das of 02 / 03/201714:53:22 
IMS - Storage and Use WETLAB_MB334_MB524 
Oescription of the work area and/or process activity [ Persons Affectitd 
Cleaners x 2 
The use of IMS far deaning and maintaining asceptic technique. The use of 70% IMS in MB334 and Postgraduate Student x 4 Staff x 4 
wet lab St11<1Antc;; x ~ 
1 Company 11 Astan University 
Si te 11 Life and Health Sciences 
Branch 1 Biology 
Substance Name 11 Emergency Tel No. 11 Usage lnformation 
Method of use: 
Substance is used at 70% dilution wi th water and is 
a Industrial Methylated Spirit +44 (0)1747 833100 sprayed on to su rfaces an d obj ects to dean th em. Substanee form: Liquid 
Duration 1 Minu te (s) 
frequenc:y Often During Day/ Shift 
1 Hazard Labelling 
Can a less hazardous substancit(s) be used to do the same job 
Control Measures 
Handle in accordance wi th good indus trial hygiene and safety practice. Wash hands befare breaks and at the end of wo·kday. 
Only authorised and trained personnel to use this substance. 
Use only in well ventilated areas. 
11 
LOW RISK 
• DDDD 
1 
11 MSDS Date IB 
25/ 08/2010 e 
NO 
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Personal Protective Equipment First Aid Measures 
~ Eye Proteetion ![JI Eye Contaet Face shield and safety glasses Use equipment far e ye Rinse thoroughly wi th plen ty of water far at least 15 minu tes and protection tested and a~proved under appropriate government \ fl l'\.$ T AIO,. consulta ph ysician . standards su ch as NIOSH (US) or EN 166(EU). 
Hand Proteetion ![JI lngestion ffjl Han dle wi th gloves . Gloves mus t be in spected prior to u se . Use Do NOT induce vomiting. Never gi ve an ything by mouth toan unconscious person . Rinse mJuth wi th water. Consulta proper glove removal tec1nique (wi thout touching glove ' s l. FI F\$ T Al i) ,, ph ysician . 
l """'º' , 
outer surface) to avoid skin contact wi th this product. Dispose 
of contaminated gloves after use in accordance wi th applicable 
IIJI Skin Contaet laws and good laboratory practices . Wash and dry hands . Wash off wi th soap and plen ty of water. Take vi ctim immediately 
f@'I l FI F\$ T AIO,. to hospital. Consulta ph ysician . Clothing 
~ c1.ono'10,. Wear laborato1y coat buttoned up . fDl lnhalation lf breathed in , move person in to fresh air. lf not breathing, gi ve 
Mask I Respirator \ FI F\.$ T AIO,. artificial respiration . Consulta ph ysician . 
Where risk assessment s~ows air-puri fyi ng respirators are 
1 1 
appropriate use a full-face respirator wi th multi -purpose IU lnjeetion ffjl combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to engineering controls . lf the respirator is the sale \ Fl li$ T 1.10 ,. Not Specified 
1,, tl A.$K ,. means of protection, use a full-face supplied air 
respirator. Use respirators and components tested and 
approved under appropriate government standards such as 
N IOSH (US) or CEN (EU). 
How the substances associated with this process should be stored 
fWl Store in cool place . Keep container tightly dosed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and 
\ STCRAGE ,. 
kept upright to prevent leakage . 
Have persons undertaking this process been provided with information or training? I~ 
Could the release of vapour/gas/dust produce an explosive atmosphere 
1 
Not Specified 1 
Is the flashpoint below 32'C for any of the substances identified 
1 
Not Specified 1 
1 What to do in the event of a fire 
rn Far small (incipient) tires, use media su ch as "alcohol" faam, dry chemical, or carbon di oxi de . Far large tires, apply water from as far as possible. Use ve ry large quan ti ti es (flooding) of water applied as a mist or spray; salid streams of water may be ineffecti ve . Cool all affected con tainers w1 th flood1ng quant1t1es of water. Wear self conta1ned breath1ng apparatus far flre flght1ng 1f necessary. Use water spray to cool cnopened containers . 
Other substance that this substance(s) must not come into contact with 
Conditions to avoid : 
Heat, llames and sparks . Extremes o' temperature and direct sunlight. 
Materials to avoid: 
acids, Acid chlorides, Acid anh ydrides, Oxi dizing agents, Alkali metals, Ammonia, Peroxi des . 
What to do in the event of a spillage 
Personal precau ti on s: 
Use personal protective equipment. Avoid breathing vapors, mist or gas . Ensure adequate ventilation . Remove all sources ofigni tion . Evacuate 
personnel to safe areas . Beware of vapours accumulating to farm explosive concentrations. Vapours can accJmulate in low areas . 
14'11 En vi ronmental precautions: 
1,, SP!ll.AG6,. 
Preven t further leakage or spillage if safe to do so . Do not let product en ter drains . Discharge in to the environmen t must be avoided. 
Methods and materials fc.r containment and deaning up : 
Contain spillage, and then collect wi th an electrically protected vacuum deaner or by wet-brushing and place in container far disposal according 
to local regula ti on s . 
How dispose of substances associated with this process 
Toxi c to aquaticlife . 
Product: 
l c.~ I Ourn in a chemical incinerator equipped wi th an afterburner and scrubber but e xe rt e xtra care in igniting as this matelial is highly flammable . Offer surplus and non -recydable solutions to ali censed disposal compan y. Contact ali censed professional waste disposal service to dispose of 
\ l)ISPOS:OI ,. this material. 
Contaminated packaging: 
Dispose of as un u sed product. 
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Health / Medica( Surveillance to be undertaken when using these substances 
Are hazards to health adequately controlled with ali the above control measures in place? 
Additional Notes I Summary 
Should pose no risk to health as long as good chemical practice is employed and these i nstructions are followed. 
Overall Residual Risk 
LOW RISK 
• DDDD 
Ph oto G allery 
NOTICE 
There are currently no photographs associated wi t h the assessment. 
Record Notes I History 
NOTICE 
There are currently no notes associated wi th the assessment. 
Yes 
1 Current Risk 
LOW RISK 
• DDDD 
1 
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Aston University 
Binningham 
COSHH Summary - 2302CA 
Assessed By PhD Student on 02 / 03 / 2017 
lnfarmation validas of 02 / 03/2017 14:52:50 
Trypan Blue WETLAB_MB334_MB524 
Oescription of the work area and/or process activity 1 Persons Affected 
Trypan blue i s a carcinogen . lf no t stored and handled proper\y, thi s can pose a serious threat to 
the health and safety oflaboratory ~ersonnel, emergency responders and chemi cal waste handlers. 
Hence, i t is i mportant to fallow safety protocols to handle thi s chemi cal. Cleaners x 2 
Trypan Blue i s a vital stain u sed to selecti vely color dead tissues or cells blue. Uve cells or tissues Postgraduate Student x 4 
wi th i nt;ict ccll mc mbrilnc ::; ;irc not colorc d . Ccll::; ;irc vcry ::;clc cti vc in th c compound::; th11t p;i::;::; St~ff X ~ 
th rough the membrane. In a vi able cell, t rypan blue i s not absorbed. However, i t traverses the Students x 3 
membrane in a dead cell. Hence, dead cells are shown as a di stincti ve blue color under a 
mi croscope. 
Company As ton Universi ty 
Si te 
1 
Life and Health Sciences 
1 Branch 1 Me di cal Sch ool 
LOW/MEDIUM 
RISK 
• llJDDD 
1 
1 
[ Substance Name 11 Emergency Tel No. 1 Usage lnformation [ MSDS Date I~ 
~ Method of use: G Trypan Blue solution Not Specified Substanoe form: Liquid +44 (0)1747 833100 07/ 0712010 Ouration Not Speci ti ed frequenc:y 
1 Hazard Labelling 
I ~· ~ toxic serious health haz 
Can a less hazardous substance(s) be used to do the same job NO 
Control Measures 
Contains no substances wi th occupational exposure limi t values. Personal, workplace atmosphere or bi ological moni tori ng may be requi red to determine the 
effecti veness of the ventilation or other control measures and/or the necessi ty to use respiratory protecti ve equi pmert. 
Use only wi th adequate ventilation . Use process endosures, local exhaust ventilation or other engineering controls to keep worker exposure to airborne 
contami nants below any recommended or statutory limits. 
Wash hands, farearms and face thoroughly after handling chemical products, befare eating, smoking and using the lavatory and at the end of the working 
period . Appropriate techni ques should be used to remove potenti ally contaminated dothi ng. Wash contami nated doth·ng befare reusing. Ensure that 
eyewash stati ons and safety shower; are dose to the workstation locati on . 
Emi ssi ons from ventilati on or work process equi pment should be checked to ensure t hey comply wi th the requirements of environmental protection 
legislation . In sorne cases, fume scrubbers, filters or engineering modi fications to the process equipment will be necessary to reduce emi ssi ons to 
acceptable levels . 
1 
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Personal Protective Equipment 11 First Aid Measures 
~ Eye Proteetion flJI Eye Contaet Safety eyewear complying wi th an approved standard should be Rinse thoroughly wi th plen ty of water far at least 15 minutes and used when a risk assessrrent indicates this is necessary to l. flf\$T 1.10 ,. consulta physician. avoid exposure to liquid ;plashes, mists, gases or dusts. 
1 ~ 1 Hand Proteetion flJI lngestion Chemical-resistant, impe-vious gloves complying wi th an Do NOT induce vomiting. Never gi ve anything by mouth toan unconscious person . Rinse mJuth wi th water.Consulta approved standard should be worn at ali times when handling \ FIF\.$T AIO,. physician. ch emi cal produ cts i f a ri sk assessmen t in di cates thi s is necessary. 
flJ 
Skin Contaet 
Clothing Take off contaminated dothing and shoes immediately. Wash off 
with soap and plenty of water. Take victim immediately to Personal protecti ve equipment far the body should be selected l FIF\.$T 1.10 .• 
hospital. Consulta physician . 
l@'I based on the task being perfarmed and the risks involved and sh ould be approved by a speci alis t befare handling thi s lnhalation 
1., Cf.,OT'·U'10,. 
product. Appropriate faot wear and any additional skin flJI lf breathed in, move person in to fresh air. lf not breathing, gi ve protection measures should be selected based on the task artificial respiration . Consulta physician. 
being perfarmed and the risks involved and should be approved l FIF\$T AIO,, Th e exposed person may n eed to be kept un der medi cal 
by a specialist befare handling this product. surveillance far 48 hours. 
Mask I Respirator fDl 
1 1 
ffil Use a property fitted, air·purifying or air-fed respirator lnjeetion complying wi th an approved standard if a risk assessment Not Specified in di cates this is necessary. Respirator selection must be based l FIF\$T AID,, 
\ rl A.$K ,. 
on known or anticipated exposure levels, the hazards of the 
product and the safe working limits of the selected respirator. 
How the substances associated with this process should be stored 
Storage dass (TRGS 510): Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects 
Store in original container protected from direct sunlight in a dry, cool and well-ventilated area, away from incompatible materials. Keep 
ftfl container tightly dosed and sealed until ready far use. Con tainers that have been opened must be carefully resealed and kept upright to prevent leakage. Do not store in unlabeled con tainers. Use appropriate containment to avoid environmental contamnation. 
\ STORAGE ,. 
Eating, drinking and smoking should be prohibi ted in areas where this material is handled, stored and processed. Workers should wash hands and 
face befare eating, drinking and smoking. Remove contaminated dothing and protecti ve equipment befare entering eating areas. Take measures 
to prevent the build up of electrostatic charge. 
Have persons undertaking this process been provided with information or training? I~ 
Could the releas& of vapour/gas/dust produce an explosive atmosphere 
1 
NO 
1 
Is the flashpoint below 32'C for any of the substances identified 
1 
NO 
1 
What to do in the event of a fire 
Use water spray, alcohol-resistant faam, dry chemical or carbon dioxide. 
Special hazards arising from the substance or mi xture : Nature of decomposition products not known. 
Promptly isolate the scere by removing ali persons from the vicinity of the incident i f there is a tire . No action shall be taken involving any 
f4i;I personal ri sk or wi th out sui table trai nin g. Do not allow run-off frorr fire-fighting to enter drains or water courses. Do not inhale explosion and combustion gases. Use cau tion when 
' 
H~t::: , applying carbon di oxide in confined spaces. Carbon di oxide can displace oxygen. Use water spray jet to protect personnel and to cool 
en dan gered con tai n ers. 
Fire-fighters should wear appropriate protecti ve equipment and self-con tained breathing apparatus (SCBA) wi th a full face-piece operated in 
positi ve pressure mode. 
Other substance that this substance(s) must not come into contact with 
Stable under recommended storage conditions. 
Incompatible materials: Strong oxidizing agents. 
What to do in the event of a spillage 
Wear respiratory protecton . Avoid breathing vapours, mis t or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. 
Soak up wi th inert absorbent material and dispose of as hazardous waste. Keep in suitable, dosed containers far disposal. 
1• 1 Approach release from upwind. Prevent entryinto sewers, water courses, basements or confined areas. 
\ SPUV.GF,. 
Avoid dispersa! of spilled material and runoff and contact wi th soil, waterways, drains and sewers. lnfarm the relevant authorities i f the product 
has caused environmen tal pollu tion (sewers, waterways, soil or air) . Preven t further leakage or spillage i f sale to do so. Do not let product enter 
drains. Discharge in to the environment must be avoided. 
Copyright Riskex Ltd 2001 - 2017 / AssessNET.co.uk Online Health and Safety Management Page 3 / 3
How dispose of substances associated with this process 
Di spose according to LHS waste poli cy. The in formation presented only applies to the material as supplied. The identification based on 
characteristic(s) orli sting may not apply i f the material has been used or otherwi se contaminated. lt i s the responsibility of the waste generator 
to determine the toxicity and physi cal properties of the material generated to determine the proper waste identification and di sposal methods 
1t.'!>1 in compliance wi th applicable regulations. Di sposal should be in accordance wi th applicable regional, national and local laws and regulations . 
1,, OISPQS:Ol ; The generation of waste should be avoided or minimized wherever possible. Waste packaging should be recyded. lncineration or landfill should 
only be considered when recyding i s no t feasible. 
Offer surplus and non-recydable solu tions to a licensed di sposal campan y. 
Health / Medica( Surveillance to be undertaken when using these substances 
1 ~ 1 
1 
Not Specified 
1,, 1.1eo1c: A.~ .. 
Are hazards to health adequately controlled with ali the above control measures in place? 
( Additional Notes I Summary 
To the best of our knowledge, the cnemical, physi cal, and toxi cological properties have not been thoroughly investigated. 
Far non-emergency personnel upan accidental release: No action shall be taken involving any personal risk or wi thout sLi table 
training. Evacuate surrounding areas. Keep unnecessary and unprotected personnel from entering. Do not touch or wal' through 
spilled material. Provide adequate ventilation . Wear appropriate respirator when ventilation i s inadequate. Put on appropriate 
personal protecti ve equipment. 
Overall Residual Risk 
LOW/MEDIUM RISK 
• llJDDD 
Ph oto G allery 
NOTICE 
There are currently no photographs associated with the assessment. 
Record Notes I History 
NOTICE 
There are currently no notes associated wi th the assessment. 
1 Yes 
lf Current Risk 
LOW/ MEDIUM RISK 
• KJDDD 
1 
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~ COSHH Summary - 2304CA 
Aston University 
Binningham 
Assessed By PhD Student on 02 / 03 / 2017 
lnformation validas of 02 /03/2017 15:04:17 
Ethanol 
Oescription of the work area and/or process activity 1 Persons Affected 
Cleaners x 6 
Postgraduate Student x 5 
Use and storage of Ethanol in Wetlab, MB334, MB524. Staff x 5 
Students x 5 
Company 11 As ton Universi ty 
Si te 11 Li fe and Health Sciences 
Branch 1 Biology 
r Substance Name 11 Emergency Tel No. H Usage lnformation 
~ Method of use: Ethanol Used as organic salven t. Substanoe form : Liq uid +44 (0)1747 833100 Ouration 3 Hours(s) frequeney When Required 
1 Haz ard Labelling 
l ~ l~I caut1on 
Can a less haz ardous substance(s) be used to do the same job 
r Control Measures 
LOW/MEDIUM 
RISK 
• llJDDD 
1 
H MSDS Date I~ 
09/ 0712015 G 
1 
NO 
Use explosion ·proof ven tilation equipmen t . Use adequate general or local exhaus t ven tilation to keep airborne caneen trations below the permissible 
exposure limits . 
Facilities storing or utilizing this material should be equipped wi th an eyewash facility anda safety shower. 
Handle in accordance wi th good industrial hygiene and safety practice. Wash hands befare breaks and at the end of wo·kday. 
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Personal Protective Equipment Fi rst Aid Measures 
~ Eye Proteetion f[JI Eye Contaet Face shield and safety glasses Use equipment far eye Rinse thoroughly wi th plen ty of water far at least 15 minutes and protection tested and a~proved under appropriate government l FIF\$T AI O,, consulta physician. standards su ch as NIOSH (US) or EN 166(EU). 
Hand Proteetion f[JI lngestion Han dle wi th gloves. Gloves mus t be in spected prior to u se. Use Do NOT induce vomiting. Never gi ve anything by mouth toan 
unconscious person. Rinse mJuth wi th water. Consulta proper glove removal tec1nique (wi thout touching glove ' s \ FI F\$ T Ali) _. 
physician. outer surface) to avoid skin contact wi th this product. Dispose 
of con tami n ated gloves after u se in accordan ce wi th appli cable IU f{fl laws and good laboratory practices. Wash and dry hands. Skin Contaet The selected protecti ve ~oves have to satisfy the 
\ FIF\$ T 1.10 .• 
Wash off wi th soap and plen ty of water. Consult a physician. 
1., HA.NOS ,, specifications of EU Directi ve 89/ 686/ EEC and the standard EN 
374 deri ved from i t. f[JI Type: butyl-rubber, 0.3mm thickness, 480min break though lnhalation 
time (full contact) lf breathed in, move person in to fresh air. lf no t breathing, gi ve 
ni trile, 0.2mm thickness, 38min break t hrough time (splash l FIF\$T AI O,. artificial respiration . Consulta physician. 
contact) 
f[JI Clothing lnjeetion 
f@'I lmpervious dothing, Flame retardan t antistatic protecti ve \ FIR.$T AI O,. Seek medica! attention. dothing., The type of protecti ve equipment must be selected 
1,,c1.ono<Ja,, accordi n g to th e con cen trati on an d amo un t of th e dan ge ro u s 
su bs tan ce at th e speci fi e workplace. 
Mask I Respirator 
Where risk assessment s~ows air-purifying respirators are 
appropriate use a full-face respirator wi th multi -purpose 
ffil combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to engineering controls. lf t he respirator is t he sote 
l rlASK ,, means of protection, use a full-face supplied air respirator. Use 
res pi rators an d campan en ts tes ted an d approved un der 
appropriate government standards su ch as NIOSH (US) or CEN 
(EU). 
How the substances associated with this process should be stored 
ftil Keep away from heat, sp3rks, and llame. Keep away from sources ofignition. Store in cool place. Keep container tightly dosed in a dry and well-ventilated place. Con tainers which are opened must be carefully resealed and 
1,, $1CRAGE,. kep t uprigh t to prevent leakage. 
Storage dass (TRGS 510): Flammable liquids 
Have persons undertaking this process been provided with information or training? '~ 
Could the release of vapour/gas/dust produce an explosive atmosphere 
1 
YES 
1 
Is the flashpoint below 32 •e for any of the substances identified 
1 
YES 
1 
What to do in the event of a fire 
rn Use water spray, alcohol-resistant faam, dry chemical or carbon dioxide. Use water spray to cool unopened containers. As in any tire, wear a self-contained breathing apparatus in pressure-demand, MSHA/ NIOSH (approved or equi valent), and full protecti ve gear. Use water spray to keep fire -exposed containers cool. Containers may explode in t he heat of a tire . 
Other substance that this substance(s) must not come into contact with 
lgni tion sources, excess heat 
Incompatible materi als: 
Alkali metals, Oxidizing agents, Pero:<ldes 
What to do in the event of a spillage 
Use personal protecti ve equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Remove all sources ofignition. Evacuate 
16'1 personnel to safe areas. Beware of vapours accumulating to farm explosive concentrations. Vapours can accJmulate in low areas. Prevent further leakage or spillage if safe to do so. Do not let product en ter drains. 
l SPUl.AGF ,. Contain spillage, and then collect wi th an electrically protected vacuum deaner or by wet-brushing and place in container far disposal according 
to local regulations. 
How dispose of substances associated with this process 
fe;l 
1 
Dilute in sink wi th excess water. 
1 
c.~ 
l OISPQS.:01,. 
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Health / Medica( Surveillance to be undertaken when using these substances 
Are hazards to health adequately controlled with ali the above control measures in place? 
Additional Notes I Summary 
Reproducti vely toxic to females through ingestion. 
Can cause n ewborn dru g dependan ce. 
Overall Residual Risk 
LOW/MEDIUM RISK 
• llJDDD 
Yes 
Current Risk 
LOW/MEDIUM RISK 
• KJDDD 
1 
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OSEAR Assessment Details for COSHH Assessment - 2304CA 
1. Does a act ivity need to be asse>sed under OSEAR 
Could the release of vapour/gas/dust produce an explosive atmosphere 
Is the flashpoint below 32°C 
2. Assessing Possible Failures: 
List any work systems or activities that could fail resulting in a List any sources of ignition fire or explosion, e.g. valves, gaskets, etc 
1 
Accidental spillage i n lab. 
1 
Electric. 
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3. Exist ing control measures for identifying hazards: 
Has the quantity of substance being held/ used been reduced to a mínimum? YES 
1 APPROXIMATE QUANTITY 
2.SL 
Have steps been taken to avoid or minimise intentional or unintentional release 
1 
YES 
1 
DETAILS 
Reagent is stored i n a sealed bottle within a ventilated metal cabinet. 
Reagen t is u sed wi thi n an effi cien t che mi cal fu me cu pboard. 
Have steps been taken to control release at sources 
1 
YES 
1 
DETAILS 
Reagent i s purchased i n limi ted quanti ty and used in an efficient chemi cal fume cupboard wi th no local source of i gni ti on. 
Have steps been taken to prevent the formation of an explosive atmosphere? 
1 
YES 
1 
DETAILS 
Substance i s handled i n an efficient chemi cal fume cupboard . 
Have steps been taken to collect, contain and remove any releases to a safe place, e.g. by ventilation? 
1 
YES 
1 
DETAILS 
Substance i s handled i n an efficient chemi cal fume cupboard . 
Have steps been taken to avoid adverse conditions, e.g. exc-ding temperature limits, control settings? 
1 
YES 
1 
DETAILS 
Substance i s handled i n an efficient chemi cal fume cupboard. 
The substance i s used according to aa:epted synthetic chemi cal procedures. 
Are incompatible substances kept apart in storage and in use, so far as is practicable, e.g. flammables and 
1 
YES 
1 
oxidisers? 
DETAILS 
The substance i s stored seperately to oxidi sers . 
Have the number of employees exposed to the dangerous substances or explosive atmosphere been reduced 
1 
YES 
1 
to the mínimum 
DETAI LS 
Substance i s only u sed by experienced operators. 
Has plant been supplied that is explosion resistant 
1 
N/ A 
Is there explosion suppression or relief provided on equipment 
1 
N/ A 
1 DETAILS 
No Details Gi ven 
Have adequate measures been taken to control or minimise the spread of fire or explosion 11 YES 
DETAILS 
Substance i s handled i n an efficient chemi cal fume cupboard. 
Has suitable PPE been provided and have operatives been trained on how to use it? 11 YES 1 
DETAILS 
Substance i s only u sed by experienced operators. 
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4. Management lssues 
Is the workplace designed, constructed and maintained, so as to provide adequate fire resistance and/or 1 
YES 
explosion relie~ 
Is a permit to work scheme used for working with the substance(s) or in the work area and are these strictly 1 YES 
enforced? . 
In the case of e xplosi ve atmospheres continue, if not proceed to section 5. 
Have ali areas been classified into zones in accordance with schedule 2 of the regulations? 
Where necessary have ali classified zones been marked at their entry points with the specified "EX" hazard 
warning sign? 
1 DETAILS 
No Details Gi ven 
Are ali classified zones appropriately protected from sources of ignition, through the selection of equipment 
B: protective systems complaint with the equipment B: protective systems intended for use in potentially 
explosive atmospheres regulations 1996? 
Have classified zones, before their first operation, been verified as being safe, by a person or organisation 
competent in the field of explosion protection? 
Are employees working in classified zones provided with clothing that does not create a risk of electrostatic 
discharge? 
1 DETAILS 
5. Storage 
Are ali flammable substances kept in a suitable fire resistant store? 
DETAILS 
Substance is stored in a flameproof ventilated cabinet. 
Are ali quantities in excess of 50 litres kept in a dedicated and appropriately protected flammable store? 
1 DETAILS 
Are ali petroleum spirits or derivatives in excess of 50 litres kept in a dedicated and appropriately protected 
petroleum store? 
1 ~::~ails Gi ven 
Where appropriate have storage areas been designed to provide explosion relief/resistance? 
Are ali incompatible substances stored apart, e.g. flammable, oxidisers, LPG, flammable gasses, 
combustibles, etc? 
Not Speci ti ed 
Not Specified 
Not Specified 
1 
Not Specified 
1 
Not Specified 
11 YES 
11 N/ A 
N/ A 
N/ A 
YES 
1 
1 
1 
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6. Emergency procedures 
Have suitable procedures been developed and communicated to staff to deal wi th 
Adverse process conditions, e.g. exceeding temperature limits, control settings, etc? 
LOCATION / REFERENCE OF THE PROCEDURE DOCUMENTATION 
No Details Gi ven 
Fire and evacuation? 
LOCATION / REFERENCE OF THE PROCEDURE DOCUMENTATION 
See universi ty evacuation procedure 
( The spUlage of dangerous substances 
LOCATION / REFERENCE OF THE PROCEDURE DOCUMENTATION 
See COSHH assessmen t 
7. Waste disposal 
Have suitable procedures been developed and communicated to staff to deal with the safe transport of 
dangerous substances? 
Have suitable procedures been developed and communicated to staff to deal with the safe disposal of 
dangerous substances and contaminated materials? 
8 lnformat ion, instruction, supervision and training 
Have the product details been communicated to ali staff? 
Has the safe system of work been communicated to ali staff 
Are only trained and competent persons involved in work with dangerous substances 
PLEASE PROVI DE DETAI LS 
The substance is used i n t he medici r al chemistry research laboratory. 
Ph oto G allery 
NOTICE 
There are currently no photographs associated with the assessment. 
Record Notes I History 
NOTICE 
There are currently no notes associated wi th the assessment. 
11 N/ A 
11 YES 
11 YFS 
YES 
YES 
1 
YES 
1 
1 
YES 
1 
1 
YES 
1 
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~ 
Aston University 
Binningham 
COSHH Summary - 2305CA 
lnternal Reference: PenStrepCOSHH 
Assessed By PhD Student on 02 / 0312017 
lnformation validas of 02 / 03/201715:10:34 
Pennicillin/Streptomycin 
Oescription of the work area and/or process activity [ Persons Affectitd 
Cleaners x 6 
Pennicillin / Streptomycin is routinely u sed asan antibiotic component of media far tissue culture Postgraduate Student x 5 
Staff x 5 in MB334, MB524 and wetlab . 
1 Company 11 Astan Universi ty 
Si te 11 Life and Health Sciences 
Branch 1 Biology 
Substance Name 11 Emergency Tel No. 
~ PEN-STREP, LIQ., 10,000 Substanoe form : Liq uid 44·141 814-6100 
1 Hazard Labelling 
I ~ 
Can a less hazardous substancit(s) be used to do the same job 
Control Measures 
Only authorised personnel to enter the laboratory. 
Only trained personnel to use the substance. 
Ensu re adequate ventilation, especially in confined areas . 
Handle in accordance wi th good industrial hygiene and safety practice 
St11<1Antc;; x 4 
11 Usage lnformation 
Method of use: 
This substance is u sed in small volumes and 
transferred from one vessel to another by using a 
serological pipette. 
Duration 5 Minute(s) 
frequeney When Required 
LOW RISK 
• DDDD 
1 
11 MSDS Date IB 
15/ 04/2010 e 
11 NO 
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r Personal Protective Equipment 11 First Aid Measures 
~ Eye Proteetion fDl Eye Contaet safety glasses wi th side-!hi elds Ri nse i mmedi ately wi th plenty of water, also under the eyelids, l FIF\$ T 1.11) .- far at least 15 mi nutes [ru Hand Proteetion flJI lngestion i mpervi ou s gloves. l. FIF\$T Al i) ,; Never gi ve an ything by mouth toan unconscious person 
ffjl Clothing flJ Skin Contaet 
\ Cl,.OHU'Je,, 
Lab coat buttoned up. 
\ FI F\$T 1.10 .• 
Wash offimmediately wi th plenty of water 
ffjl Mask I Respirator ~ 1 lnhalation 1 In case ofinsufficient ve1tilation wear sui table respiratory Move to fresh ai r \ rlA$K ,, equipment 
~ I lnjeetion 
1 
Not Speci fi ed 
How the substances associated with this process should be stored 
IWI I "'·' , . prop .. , ..,, ... , ~· ,. •• " 
1 
\ S'TCRAGE,, 
Have persons undertaking this process been provided with information or training? I~ 
Could the release of vapour/gas/dust produce an explosive atmosphere 
1 
Not Specified 1 
Is the flashpoint below 32°C for any of the substances identified 
1 
Not Specified 1 
1 What to do in the event of a fire 
rn dry chemi cal. Wear self-contained breathing apparatus and protecti ve sui t. 
What to do in the event of a spillage 
14'11 Use personal protecti ve equipment 
!,, $PUV\GE,. Soak up wi th i nert absorbent material. 
How dispose of substances associated with this process 
1 &~ 1 Di spose of i n accordan ce wi th local regulati on s. 
l OISPOS.:01,, 
Are hazards to health adequately controlled with ali the above control measures in place? 
Additional Notes I Summary 
This substance presents no risk to health as long as good chemical practice i s observed. 
Overall Residual Risk 
LOW RISK 
• DDDD 
Ph oto G allery 
NOTICE 
There are cu rrently no photographs associated wi t h the assessment. 
Yes 
1 Current Risk 
LOW RISK 
• DDDD 
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~ 
Aston University 
Binningham 
COSHH Summary - 2316CA 
Assessed By PhD Student on 20 / 03 / 2017 
lnformation valid as of 20/ 03/2017 14:51 :42 
Teepol Bleach - Storage and Use WETLAB_MB334_MB524 
1 Oescription of the work area and/or process activity 
1 Company 11 As ton Universi ty 
Si te 11 Li fe and Health Sciences 
Branch 1 Biology 
111 :;;~~~:.:"' " 
Staff x 4 
Students x 3 
r Substance Name H Emergency Tel No. H Usage lnformation 
Method of use: 
Use only as di rected on the container orlabel. 
Provide good ventilati on in working area. Wash 
han ds after u se an d do n ot allow to en ter su rface 
~ Teepol Multi purpose Detergent water drai ns. 01689 877020 Store only i n original con tainers out of reach of Substance form: Liquid 
children . Storage temperature should be between 
s ·c and 3o ·c . 
Ouration 10 Minute(s) 
frequeney Weekly 
Can a less hazardous substance(s) be used to do the same job 
Control Measures 
Not Specified 
MEDIUM RISK 
• llJD DD 
H MSDS Date '~ 
28/ 02 / 2007 e 
NO 
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Personal Protective Equipment First Aid Measures 
~ Eye Proteetion ![JI Eye Contac:t Tightly fitting safety goo~es . lrri gate wi th water far 1 O to f 5 minutes un til irrita ti on su bsi des . l. FIF\$T 1.11),, lf irri tation persists seek medica! attention . [ru Hand Proteetion IU lngestion Han dle wi th gloves. Use proper glove removal te ch ni que to lf conscious, gi ve plenty of water to drink, do not induce avoid skin contact. \ FI F\$T 1.10 .• vomi ting, obtain medica! attention immediately. 
ffjl Clothing ![JI Skin Contac:t Complete sui t protecting against chemicals . Wash splashes from skin immediately. lf skin becomes sore or 
\ Cl.OT"il 'lO,, l FIF\$T AIO,. in flamed seek medica! attention. 
ft: Mask I Respirator ![JI lnhalation Provi de adeq u ate ven tilati on . \ FIR.$T AIO,. En su re supply of fresh air and seek medica! atten tion . 
IU 
1 
lnjeetion 
1 
1,, FI F;:$T 1.10 ,. Not Specified 
How the substances associated with this process should be stored 
flrl Store only in original containers out of reach of children . Storage temperature should be between 5 ' C and 30 ' C. 
l $10RAGE ,. 
Have persons undertaking this process been provided with information or training? I~ 
Could the release of vapour/gas/dust produce an explosive atmosphere 
1 
NO 
1 
Is the flashpoint below 32 •e for any of the substances identified 
1 
NO 
1 
1 What to do in the event of a fire 
r What to do in the event of a spillage 
l~ I Remove contaminated dothing. Small spillages may be flu sh ed to a faul drai n. Wash splashes from skin immediately. lf skin becomes sore or inflamed seek medica! attention . 
1,, SP'l lAGF,. lrrigate wi th water far 10 to 15 minutes until irri tation subsides . lf irritation persists seek medica! attention. 
How dispose of substances associated with this process 
1c.'!>1 When disposing of surplus or waste product use sui table PPE etc. ensuring empty containers are rinsed out and disposed of safely. Do not allow 
1,, OISPOS:Ol ,, 
product to enterland or su rface water drains . Dispose of in accordance wi th local authority regulations. Do not mix wi th other waste materials. 
Health / Medica( Surveillance to be undertaken when using these substances 
1 & 1 
1 
Not Specified 
\ t.,eOICA.1. ,, 
Are haz ards to health adequately controlled with ali the above control measures in place? 
Additional Notes / Summary 
Should pose no risk to health as long as good chemical practice is observed and the specific instructions gi ven in this COSHH 
Assessmen t are adh ered to . 
Overall Residual Risk 
MEDIUM RISK 
• E DDD 
Yes 
11 Current Risk 
MEDIUM RISK 
• KJD DD 
1 
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Ph oto G allery 
NOTICE 
There are currently no photographs associated with the assessment. 
Record Notes I History 
NOTICE 
There are currently no notes associated with the assessment. 
B
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Cataract Surgery - Aston Biological Eye Model  Participant Feedback Form 
  Menduni, Francesco 
 
Non cataractous porcine eye 
 
Year of Training:  No. of Cases performed:  
2 
 0-50  
50-100 
100-200                    X 
200-300 
300-500 
500-1000 
1000 + 
Surgical Step/Tissue Score 1 – 5 (worst to best) Comments 
Cornea 4 
Clear, thicker and slightly tougher 
than human cornea. Need to adjust 
incision architecture. 
Incisions 4  
Iris 2 
Iris is slightly floppy and pupil is 
generally small. It may respond to 
intracameral mydratic like 
phenylephrine. Would work well as 
model for floppy iris cases. 
Lens capsule 4 
Thicker and tougher than human 
capsule. Very elastic like young 
human capsule. Although it is not 
close to routine senile cataract 
cases it does simulate a tense and 
elastic capsule well and would be 
good to challenge these skills. 
Continuous Curvilinear 
Capsulorhexis 4 
 
Hydro Dissection 2 
Lens is soft and essentially normal 
so hydrodissection is easier. It is 
therefore difficult to judge how 
good your technique is. 
Phacoemulsification 2 
The lens is soft and no phaco-power 
is required to remove the lens, 
however this is a good simulation 
where a young patient may require 
cataract surgery. 
Soft Lens Matter Removal 1 Essentially no soft lens matter remnants as nucleus is so soft. 
Intra ocular lens insertion 5 Very realistic anatomical dimensions therefore very realistic. 
General/Other  
Anatomical dimensions are close to 
human so it is a good simulation 
tool. 
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Cataract Surgery - Aston Biological Eye Model  Participant Feedback Form 
  Menduni, Francesco 
 
Cataractous porcine eye 
 
Year of Training:  No. of Cases performed:  
2 
 0-50  
50-100 
100-200                    X 
200-300 
300-500 
500-1000 
1000 + 
Surgical Step/Tissue Score 1 – 5 (worst to best) Comments 
Cornea 2 
The cornea appeared to be 
decompensating, view became 
difficult during procedure 
Incisions 4  
Iris 2 
Iris is slightly floppy and pupil is 
generally small. It may respond to 
intracameral mydratic like 
phenylephrine. Would work well as 
model for floppy iris cases. 
Lens capsule 4 
Brittle and easy to create a 
capsulorhexis. More similar to a 
senile lens capsule. 
Continuous Curvilinear 
Capsulorhexis 4 
As above 
Hydro Dissection 2 
Not able to perform effectively 
likely due to the posterior nature 
of the induced cataract. 
Phacoemulsification 2 
Posterior cataract. Anterior of lens 
was quite soft with the posterior 
aspect being very dense and 
difficult to phacoemulsify. 
Soft Lens Matter Removal 1 
Minimal soft lens matter, however 
difficult to judge extent as the 
corneal view was compromised. 
Intra ocular lens insertion 5 Very realistic anatomical dimensions therefore very realistic. 
General/Other  
The cataract model does indeed 
provide a new challenge. It is 
difficult to gauge the utility in view 
of the poorer corneal view.  
 
